| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.66e-10 | 35 | 230 | 9 | GO:0015020 |
| GeneOntologyMolecularFunction | retinoic acid binding | 6.99e-10 | 28 | 230 | 8 | GO:0001972 | |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | UGT2A2 GALNTL6 OGT UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 GXYLT2 WDFY3 | 2.58e-08 | 153 | 230 | 13 | GO:0008194 |
| GeneOntologyMolecularFunction | retinoid binding | 6.96e-08 | 48 | 230 | 8 | GO:0005501 | |
| GeneOntologyMolecularFunction | isoprenoid binding | 8.24e-08 | 49 | 230 | 8 | GO:0019840 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | AGAP5 DOCK11 RAPGEF5 MCF2L2 AGAP11 CHN1 CHN2 ARHGEF9 ARHGAP29 RABGEF1 VAV1 FGD3 DOCK3 PSD2 RASGRF1 OPHN1 ARHGEF10 DEPDC5 AGAP9 NCKAP1L | 1.86e-06 | 507 | 230 | 20 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | AGAP5 DOCK11 RAPGEF5 MCF2L2 AGAP11 CHN1 CHN2 ARHGEF9 ARHGAP29 RABGEF1 VAV1 FGD3 DOCK3 PSD2 RASGRF1 OPHN1 ARHGEF10 DEPDC5 AGAP9 NCKAP1L | 1.86e-06 | 507 | 230 | 20 | GO:0030695 |
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1A MYO5A ERCC6L MYO5B MYO7B ABCA13 MCM7 CHD2 ABCA10 ZRANB3 UBA1 MOV10L1 KIF5A ATG7 CECR2 KIF21A SMC6 DNAH2 RFC3 RFC5 MYO15A ATP6V0A2 | 2.71e-06 | 614 | 230 | 22 | GO:0140657 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | UGT2A2 GALNTL6 OGT UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 WDFY3 | 6.46e-06 | 211 | 230 | 12 | GO:0016758 |
| GeneOntologyMolecularFunction | lipid binding | AGAP5 GC AGAP11 F2 CHPT1 PIK3C2G BAIAP3 SEC14L4 PICK1 BIN1 PSD2 OGT UGT1A10 UGT1A8 UGT1A7 UGT1A5 NUMA1 UGT1A9 APOB OPHN1 UGT1A4 UGT1A1 UGT1A3 TLR2 WDFY3 AGAP9 EPB41 | 2.88e-05 | 988 | 230 | 27 | GO:0008289 |
| GeneOntologyMolecularFunction | glycosyltransferase activity | UGT2A2 GALNTL6 OGT UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 GXYLT2 WDFY3 | 3.15e-05 | 288 | 230 | 13 | GO:0016757 |
| GeneOntologyMolecularFunction | monocarboxylic acid binding | 3.36e-05 | 107 | 230 | 8 | GO:0033293 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 6.76e-05 | 118 | 230 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | microfilament motor activity | 7.15e-05 | 38 | 230 | 5 | GO:0000146 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | DOCK11 RAPGEF5 MCF2L2 ARHGEF9 RABGEF1 VAV1 FGD3 DOCK3 PSD2 RASGRF1 ARHGEF10 | 7.98e-05 | 231 | 230 | 11 | GO:0005085 |
| GeneOntologyMolecularFunction | enzyme regulator activity | A2M AGAP5 DOCK11 RAPGEF5 MCF2L2 AGAP11 CHN1 CHN2 TAOK2 ARHGEF9 ARHGAP29 CCNA1 RABGEF1 C5 VAV1 FGD3 DOCK3 PPP4R1 BIN1 PSD2 RASGRF1 UGT1A10 UGT1A8 UGT1A7 UGT1A9 OPHN1 UGT1A1 CCNG2 ARHGEF10 PPP1R2C DEPDC5 AGAP9 NCKAP1L | 8.77e-05 | 1418 | 230 | 33 | GO:0030234 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | HAUS6 MYO1A MYO5A MYO5B TRPM7 MYO7B GC NEB TAOK2 KLHL3 BRCA2 KCNE1 CXCR4 KIF5A AGBL1 PICK1 BIN1 ANK1 VEZT KIF21A NUMA1 OPHN1 FMNL3 ARHGEF10 SBDS MYO15A EPB41 | 1.72e-04 | 1099 | 230 | 27 | GO:0008092 |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | ERCC6L MCM7 CHD2 ZRANB3 NIPBL DNMT1 CECR2 RFC3 RFC5 N4BP2 TOP1 | 2.41e-04 | 262 | 230 | 11 | GO:0140097 |
| GeneOntologyMolecularFunction | interleukin-1 binding | 3.07e-04 | 12 | 230 | 3 | GO:0019966 | |
| GeneOntologyMolecularFunction | chloride:bicarbonate antiporter activity | 3.96e-04 | 13 | 230 | 3 | GO:0140900 | |
| GeneOntologyMolecularFunction | bicarbonate:monoatomic anion antiporter activity | 3.96e-04 | 13 | 230 | 3 | GO:0140829 | |
| GeneOntologyMolecularFunction | actin binding | MYO1A MYO5A MYO5B TRPM7 MYO7B GC NEB KLHL3 CXCR4 PICK1 BIN1 OPHN1 FMNL3 MYO15A EPB41 | 4.66e-04 | 479 | 230 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 6.81e-04 | 127 | 230 | 7 | GO:0008094 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 8.40e-04 | 37 | 230 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | protein kinase C binding | 9.80e-04 | 66 | 230 | 5 | GO:0005080 | |
| GeneOntologyMolecularFunction | actin filament binding | 1.31e-03 | 227 | 230 | 9 | GO:0051015 | |
| GeneOntologyMolecularFunction | GTPase activator activity | AGAP5 AGAP11 CHN1 CHN2 ARHGAP29 DOCK3 OPHN1 DEPDC5 AGAP9 NCKAP1L | 1.53e-03 | 279 | 230 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | carboxylic acid binding | GLDC UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.87e-03 | 239 | 230 | 9 | GO:0031406 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ERCC6L MYO5B ABCA13 MCM7 CHD2 ABCA10 MOV10L1 KIF5A KIF21A SMC6 DNAH2 RFC3 RFC5 | 1.89e-03 | 441 | 230 | 13 | GO:0016887 |
| GeneOntologyMolecularFunction | single-stranded DNA helicase activity | 2.25e-03 | 23 | 230 | 3 | GO:0017116 | |
| GeneOntologyMolecularFunction | helicase activity | 2.41e-03 | 158 | 230 | 7 | GO:0004386 | |
| GeneOntologyBiologicalProcess | cellular glucuronidation | UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.51e-13 | 21 | 223 | 9 | GO:0052695 |
| GeneOntologyBiologicalProcess | glucuronate metabolic process | UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.57e-12 | 26 | 223 | 9 | GO:0019585 |
| GeneOntologyBiologicalProcess | uronic acid metabolic process | UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.57e-12 | 26 | 223 | 9 | GO:0006063 |
| GeneOntologyBiologicalProcess | flavonoid glucuronidation | 1.41e-10 | 5 | 223 | 5 | GO:0052696 | |
| GeneOntologyBiologicalProcess | flavone metabolic process | 8.40e-10 | 6 | 223 | 5 | GO:0051552 | |
| GeneOntologyBiologicalProcess | flavonoid metabolic process | 2.41e-09 | 13 | 223 | 6 | GO:0009812 | |
| GeneOntologyBiologicalProcess | estrogen catabolic process | 6.59e-08 | 5 | 223 | 4 | GO:0006711 | |
| GeneOntologyBiologicalProcess | xenobiotic glucuronidation | 1.05e-07 | 12 | 223 | 5 | GO:0052697 | |
| GeneOntologyBiologicalProcess | phenylpropanoid catabolic process | 1.96e-07 | 6 | 223 | 4 | GO:0046271 | |
| GeneOntologyBiologicalProcess | coumarin catabolic process | 1.96e-07 | 6 | 223 | 4 | GO:0046226 | |
| GeneOntologyBiologicalProcess | estrogen metabolic process | 1.39e-06 | 52 | 223 | 7 | GO:0008210 | |
| GeneOntologyBiologicalProcess | phenylpropanoid metabolic process | 2.65e-06 | 10 | 223 | 4 | GO:0009698 | |
| GeneOntologyBiologicalProcess | coumarin metabolic process | 2.65e-06 | 10 | 223 | 4 | GO:0009804 | |
| GeneOntologyBiologicalProcess | pigment metabolic process | 8.25e-06 | 94 | 223 | 8 | GO:0042440 | |
| GeneOntologyBiologicalProcess | regulation of small GTPase mediated signal transduction | CHN1 CHN2 ARHGEF9 ARHGAP29 RABGEF1 VAV1 FGD3 DOCK3 SEMA4D PSD2 OGT RASGRF1 OPHN1 ARHGEF10 | 1.71e-05 | 333 | 223 | 14 | GO:0051056 |
| GeneOntologyBiologicalProcess | actin filament-based process | ADCY10 MYO1A MYO5A MYO5B TRPM7 MYO7B NEB TAOK2 KCNE1 PICK1 FGD3 AKAP6 BIN1 WASHC4 OPHN1 SLC4A2 FMNL3 LIMK2 ARHGEF10 MTOR TLR2 TTC17 MYO15A EPB41 NCKAP1L | 1.94e-05 | 912 | 223 | 25 | GO:0030029 |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | MYO1A MYO5A MYO5B TRPM7 MYO7B NEB TAOK2 PICK1 FGD3 BIN1 WASHC4 OPHN1 SLC4A2 FMNL3 LIMK2 ARHGEF10 MTOR TLR2 TTC17 MYO15A EPB41 NCKAP1L | 6.35e-05 | 803 | 223 | 22 | GO:0030036 |
| GeneOntologyBiologicalProcess | steroid metabolic process | CYP8B1 UGT2A2 GC UGT1A10 UGT1A8 UGT1A7 TECR UGT1A9 APOB UGT1A4 UGT1A1 UGT1A3 SNAI2 HSD17B12 | 6.42e-05 | 376 | 223 | 14 | GO:0008202 |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 6.83e-05 | 40 | 223 | 5 | GO:0042573 | |
| GeneOntologyBiologicalProcess | hormone catabolic process | 6.89e-05 | 21 | 223 | 4 | GO:0042447 | |
| GeneOntologyBiologicalProcess | positive regulation of GTPase activity | AGAP5 DOCK11 AGAP11 CHN1 CHN2 ARHGAP29 VAV1 SEMA4D RASGRF1 ARHGEF10 AGAP9 | 7.43e-05 | 244 | 223 | 11 | GO:0043547 |
| GeneOntologyBiologicalProcess | regulation of GTPase activity | AGAP5 DOCK11 AGAP11 CHN1 CHN2 ARHGAP29 VAV1 FGD3 SEMA4D RASGRF1 ARHGEF10 MTOR AGAP9 | 7.75e-05 | 335 | 223 | 13 | GO:0043087 |
| GeneOntologyBiologicalProcess | vitamin D metabolic process | 1.00e-04 | 23 | 223 | 4 | GO:0042359 | |
| GeneOntologyBiologicalProcess | chromatin organization | ERCC6L NOC2L CHD2 SSRP1 YTHDC1 ZRANB3 BRCA2 H4C1 MOV10L1 NIPBL DNMT1 MMS22L OGT ATG7 CECR2 SMC6 BRD3 JMJD1C KMT2D PBRM1 TADA2B SNAI2 TOP1 | 1.14e-04 | 896 | 223 | 23 | GO:0006325 |
| GeneOntologyBiologicalProcess | bilirubin conjugation | 1.16e-04 | 2 | 223 | 2 | GO:0006789 | |
| GeneOntologyBiologicalProcess | negative regulation of cardiac muscle cell contraction | 1.16e-04 | 2 | 223 | 2 | GO:0106135 | |
| GeneOntologyBiologicalProcess | anatomical structure maturation | PSEN1 PSEN2 MYO5A BRCA2 KCNE1 BAIAP3 PICK1 SEMA4D SLC26A3 STK31 MTOR RBPJ HES5 | 1.34e-04 | 354 | 223 | 13 | GO:0071695 |
| GeneOntologyBiologicalProcess | cellular process involved in reproduction in multicellular organism | ADCY10 TTC21A YTHDC1 DCST1 FSIP2 MEI4 BRCA2 CXCR4 ASPM SLC26A3 CCDC146 PRAMEF17 STK31 KMT2D MTOR CFAP58 | 2.11e-04 | 527 | 223 | 16 | GO:0022412 |
| GeneOntologyBiologicalProcess | germ cell development | ADCY10 TTC21A YTHDC1 FSIP2 MEI4 BRCA2 CXCR4 ASPM SLC26A3 CCDC146 PRAMEF17 STK31 KMT2D MTOR CFAP58 | 2.55e-04 | 482 | 223 | 15 | GO:0007281 |
| GeneOntologyBiologicalProcess | positive regulation of chromosome segregation | 2.55e-04 | 29 | 223 | 4 | GO:0051984 | |
| GeneOntologyBiologicalProcess | hair follicle maturation | 2.55e-04 | 29 | 223 | 4 | GO:0048820 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | DOCK11 RAPGEF5 CHN1 CHN2 ARHGEF9 ARHGAP29 RABGEF1 VAV1 FGD3 DOCK3 SEMA4D PSD2 OGT RASGRF1 OPHN1 ARHGEF10 | 2.65e-04 | 538 | 223 | 16 | GO:0007264 |
| GeneOntologyBiologicalProcess | actin filament-based movement | 2.66e-04 | 153 | 223 | 8 | GO:0030048 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | MYO1A MYO7B TMEM63B CHRNA5 KCNE1 CXCR4 NIPBL TIMM10 SNAI2 MYO15A | 2.78e-04 | 238 | 223 | 10 | GO:0050954 |
| GeneOntologyBiologicalProcess | developmental maturation | PSEN1 PSEN2 MYO5A BRCA2 KCNE1 BAIAP3 PICK1 SEMA4D SLC26A3 VEZT STK31 MTOR RBPJ HES5 | 3.20e-04 | 439 | 223 | 14 | GO:0021700 |
| GeneOntologyBiologicalProcess | porphyrin-containing compound catabolic process | 3.29e-04 | 13 | 223 | 3 | GO:0006787 | |
| GeneOntologyBiologicalProcess | tetrapyrrole catabolic process | 4.16e-04 | 14 | 223 | 3 | GO:0033015 | |
| GeneOntologyBiologicalProcess | sexual reproduction | ADCY10 MAGOH TTC21A MCM7 YTHDC1 DCST1 FSIP2 MEI4 BRCA2 CXCR4 MOV10L1 NCAPD2 ASPM CCNA1 KRT9 SLC26A3 CCDC146 CECR2 NUMA1 APOB PRAMEF17 STK31 SLC4A2 LIMK2 KMT2D MTOR CFAP58 RNF212B | 4.51e-04 | 1312 | 223 | 28 | GO:0019953 |
| GeneOntologyBiologicalProcess | steroid catabolic process | 4.78e-04 | 34 | 223 | 4 | GO:0006706 | |
| GeneOntologyBiologicalProcess | synapse organization | PSEN1 PSEN2 MYO5A MYO5B ADGRB2 TAOK2 ARHGEF9 PICK1 SEMA4D OGT VEZT CNKSR2 OPHN1 IL1RAPL1 TLR2 CTNND2 CDH9 NPAS4 | 4.91e-04 | 685 | 223 | 18 | GO:0050808 |
| GeneOntologyCellularComponent | somatodendritic compartment | ADCY10 PSEN1 MYO1A PSEN2 MYO5A MYO5B TRPM7 CHRNA5 SLC12A5 TAOK2 RABGEF1 KIF5A PICK1 BIN1 PSD2 OGT RASGRF1 KIF21A NUMA1 MAGOHB CNKSR2 APOB OPHN1 IL1RAPL1 MTOR WDFY3 CTNND2 TOP1 CDH9 | 8.74e-05 | 1228 | 230 | 29 | GO:0036477 |
| GeneOntologyCellularComponent | nuclear chromosome | MCM7 ZRANB3 MEI4 NCAPG BRCA2 NCAPD2 MMS22L OGT PBRM1 TOP1 RNF212B | 1.24e-04 | 254 | 230 | 11 | GO:0000228 |
| GeneOntologyCellularComponent | ATPase inhibitor complex | 3.59e-04 | 3 | 230 | 2 | GO:1903503 | |
| GeneOntologyCellularComponent | exon-exon junction subcomplex mago-y14 | 3.59e-04 | 3 | 230 | 2 | GO:1990501 | |
| GeneOntologyCellularComponent | neuronal cell body | ADCY10 PSEN1 MYO1A PSEN2 MYO5A MYO5B TRPM7 CHRNA5 SLC12A5 KIF5A PSD2 OGT RASGRF1 NUMA1 MAGOHB CNKSR2 APOB MTOR WDFY3 CTNND2 TOP1 | 3.83e-04 | 835 | 230 | 21 | GO:0043025 |
| GeneOntologyCellularComponent | myosin complex | 4.77e-04 | 59 | 230 | 5 | GO:0016459 | |
| GeneOntologyCellularComponent | condensed chromosome | PSEN1 PSEN2 ERCC6L MEI4 NCAPG BRCA2 NCAPD2 SMC6 ZNF692 PBRM1 RNF212B | 6.25e-04 | 307 | 230 | 11 | GO:0000793 |
| GeneOntologyCellularComponent | cell body | ADCY10 PSEN1 MYO1A PSEN2 MYO5A MYO5B TRPM7 CHRNA5 SLC12A5 KIF5A PSD2 OGT RASGRF1 NUMA1 MAGOHB CNKSR2 APOB MTOR TLR2 WDFY3 CTNND2 TOP1 | 6.25e-04 | 929 | 230 | 22 | GO:0044297 |
| GeneOntologyCellularComponent | FACT complex | 7.13e-04 | 4 | 230 | 2 | GO:0035101 | |
| GeneOntologyCellularComponent | chromosomal region | PSEN1 PSEN2 ERCC6L MCM7 NCAPG BRCA2 H4C1 NCAPD2 CDC73 DNMT1 SMC6 ZNF692 PBRM1 | 8.31e-04 | 421 | 230 | 13 | GO:0098687 |
| Domain | UDPGT | 7.48e-11 | 21 | 227 | 8 | PF00201 | |
| Domain | UDPGT | 7.48e-11 | 21 | 227 | 8 | PS00375 | |
| Domain | UDP_glucos_trans | 7.48e-11 | 21 | 227 | 8 | IPR002213 | |
| Domain | ARM-type_fold | USP34 DOCK11 NOC2L NCAPG PIK3C2G NCAPD2 ASPM AGBL1 NIPBL DOCK3 PPP4R1 APOB FMNL3 IFRD1 MTOR IQCB1 INTS4 WDFY3 CTNND2 | 3.62e-08 | 339 | 227 | 19 | IPR016024 |
| Domain | PH_dom-like | AGAP5 DOCK11 MYO7B MCF2L2 AGAP11 SSRP1 MTMR10 AFAP1L1 ARHGEF9 VAV1 FGD3 PSD2 RASGRF1 CNKSR2 OPHN1 ARHGEF10 WDFY3 AGAP9 EPB41 | 1.21e-06 | 426 | 227 | 19 | IPR011993 |
| Domain | IQ | 2.32e-06 | 71 | 227 | 8 | PF00612 | |
| Domain | - | AGAP5 DOCK11 MYO7B MCF2L2 AGAP11 SSRP1 MTMR10 AFAP1L1 ARHGEF9 VAV1 FGD3 PSD2 RASGRF1 CNKSR2 OPHN1 AGAP9 EPB41 | 6.31e-06 | 391 | 227 | 17 | 2.30.29.30 |
| Domain | IQ | 6.31e-06 | 81 | 227 | 8 | SM00015 | |
| Domain | IQ_motif_EF-hand-BS | 1.39e-05 | 90 | 227 | 8 | IPR000048 | |
| Domain | P-loop_NTPase | ADCY10 MYO1A MYO5A ERCC6L MYO5B MYO7B ABCA13 MCM7 CHD2 ABCA10 ZRANB3 ARL5C MOV10L1 ASPM KIF5A NLRP13 KIF21A SMC6 DNAH2 RFC3 RFC5 GNA14 N4BP2 IQCB1 AGAP9 MYO15A | 1.42e-05 | 848 | 227 | 26 | IPR027417 |
| Domain | IQ | 1.76e-05 | 93 | 227 | 8 | PS50096 | |
| Domain | PH | AGAP5 DOCK11 MCF2L2 AGAP11 AFAP1L1 ARHGEF9 VAV1 FGD3 PSD2 RASGRF1 CNKSR2 OPHN1 AGAP9 | 3.77e-05 | 278 | 227 | 13 | SM00233 |
| Domain | PH_DOMAIN | AGAP5 DOCK11 MCF2L2 AGAP11 AFAP1L1 ARHGEF9 VAV1 FGD3 PSD2 RASGRF1 CNKSR2 OPHN1 AGAP9 | 3.91e-05 | 279 | 227 | 13 | PS50003 |
| Domain | PH_domain | AGAP5 DOCK11 MCF2L2 AGAP11 AFAP1L1 ARHGEF9 VAV1 FGD3 PSD2 RASGRF1 CNKSR2 OPHN1 AGAP9 | 4.06e-05 | 280 | 227 | 13 | IPR001849 |
| Domain | HEAT | 7.21e-05 | 58 | 227 | 6 | IPR000357 | |
| Domain | Myosin_head_motor_dom | 9.19e-05 | 38 | 227 | 5 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 9.19e-05 | 38 | 227 | 5 | PS51456 | |
| Domain | Myosin_head | 9.19e-05 | 38 | 227 | 5 | PF00063 | |
| Domain | MYSc | 9.19e-05 | 38 | 227 | 5 | SM00242 | |
| Domain | ARM-like | NCAPG NCAPD2 ASPM AGBL1 NIPBL PPP4R1 IFRD1 MTOR IQCB1 INTS4 WDFY3 CTNND2 | 1.21e-04 | 270 | 227 | 12 | IPR011989 |
| Domain | Presenilin | 1.47e-04 | 2 | 227 | 2 | PF01080 | |
| Domain | Peptidase_A22A | 1.47e-04 | 2 | 227 | 2 | IPR001108 | |
| Domain | Cohesin_HEAT | 1.47e-04 | 2 | 227 | 2 | PF12765 | |
| Domain | CHN1/CHN2 | 1.47e-04 | 2 | 227 | 2 | IPR017356 | |
| Domain | - | 1.47e-04 | 2 | 227 | 2 | 3.30.1560.10 | |
| Domain | Cohesin_HEAT | 1.47e-04 | 2 | 227 | 2 | IPR026003 | |
| Domain | RhoGEF | 1.76e-04 | 68 | 227 | 6 | SM00325 | |
| Domain | RhoGEF | 2.07e-04 | 70 | 227 | 6 | PF00621 | |
| Domain | DH_2 | 2.07e-04 | 70 | 227 | 6 | PS50010 | |
| Domain | - | 2.24e-04 | 71 | 227 | 6 | 1.20.900.10 | |
| Domain | DH-domain | 2.24e-04 | 71 | 227 | 6 | IPR000219 | |
| Domain | - | NCAPG NCAPD2 ASPM NIPBL PPP4R1 IFRD1 MTOR INTS4 WDFY3 CTNND2 | 4.00e-04 | 222 | 227 | 10 | 1.25.10.10 |
| Domain | Mago_nashi | 4.38e-04 | 3 | 227 | 2 | PF02792 | |
| Domain | Mago_nashi | 4.38e-04 | 3 | 227 | 2 | IPR004023 | |
| Domain | Pur_nucleotidase | 4.38e-04 | 3 | 227 | 2 | IPR016695 | |
| Domain | PH | DOCK11 AGAP11 AFAP1L1 ARHGEF9 VAV1 FGD3 PSD2 RASGRF1 CNKSR2 OPHN1 | 5.11e-04 | 229 | 227 | 10 | PF00169 |
| Domain | SH3_2 | 6.31e-04 | 86 | 227 | 6 | PF07653 | |
| Domain | SH3_2 | 6.31e-04 | 86 | 227 | 6 | IPR011511 | |
| Domain | HAD-SF_hydro_IG_5-nucl | 8.68e-04 | 4 | 227 | 2 | IPR008380 | |
| Domain | 5_nucleotid | 8.68e-04 | 4 | 227 | 2 | PF05761 | |
| Domain | KCL_cotranspt | 8.68e-04 | 4 | 227 | 2 | IPR000076 | |
| Domain | DH_1 | 1.01e-03 | 63 | 227 | 5 | PS00741 | |
| Domain | Myosin_S1_N | 1.44e-03 | 5 | 227 | 2 | IPR008989 | |
| Pathway | REACTOME_GLUCURONIDATION | UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.04e-12 | 24 | 182 | 9 | MM14599 |
| Pathway | REACTOME_GLUCURONIDATION | UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.40e-11 | 25 | 182 | 9 | M17787 |
| Pathway | WP_GLUCURONIDATION | UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.40e-11 | 25 | 182 | 9 | MM15820 |
| Pathway | WP_GLUCURONIDATION | UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.11e-11 | 26 | 182 | 9 | M39404 |
| Pathway | KEGG_ASCORBATE_AND_ALDARATE_METABOLISM | 5.93e-10 | 25 | 182 | 8 | M605 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 1.65e-09 | 28 | 182 | 8 | M19580 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | BLVRB UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.01e-09 | 41 | 182 | 9 | M7399 |
| Pathway | REACTOME_ASPIRIN_ADME | UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.86e-09 | 45 | 182 | 9 | MM15694 |
| Pathway | WP_ESTROGEN_METABOLISM | 7.71e-09 | 22 | 182 | 7 | MM15888 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.87e-08 | 52 | 182 | 9 | M14171 | |
| Pathway | KEGG_STEROID_HORMONE_BIOSYNTHESIS | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 HSD17B12 | 3.12e-08 | 55 | 182 | 9 | M14933 |
| Pathway | REACTOME_ASPIRIN_ADME | 7.89e-08 | 44 | 182 | 8 | M45014 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 2.62e-07 | 51 | 182 | 8 | M17726 | |
| Pathway | REACTOME_DRUG_ADME | UGT2A2 VAV1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.42e-06 | 109 | 182 | 10 | M45012 |
| Pathway | KEGG_RETINOL_METABOLISM | 1.58e-06 | 64 | 182 | 8 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 3.16e-06 | 70 | 182 | 8 | M16794 | |
| Pathway | REACTOME_DRUG_ADME | UGT2A2 VAV1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 3.17e-06 | 119 | 182 | 10 | MM15692 |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 3.91e-06 | 72 | 182 | 8 | M9257 | |
| Pathway | REACTOME_HEME_DEGRADATION | 4.50e-06 | 20 | 182 | 5 | MM14721 | |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.89e-06 | 107 | 182 | 9 | MM14595 |
| Pathway | REACTOME_PHASE_II_CONJUGATION_OF_COMPOUNDS | UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.15e-05 | 109 | 182 | 9 | M18788 |
| Pathway | WP_CODEINE_AND_MORPHINE_METABOLISM | 2.43e-05 | 14 | 182 | 4 | M39328 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION | CYP8B1 UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.93e-05 | 153 | 182 | 10 | MM15844 |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 5.15e-05 | 32 | 182 | 5 | MM14719 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 5.50e-05 | 76 | 182 | 7 | M19832 | |
| Pathway | WP_ESTROGEN_METABOLISM_WP697 | 7.14e-05 | 18 | 182 | 4 | M39424 | |
| Pathway | REACTOME_PARACETAMOL_ADME | 1.37e-04 | 39 | 182 | 5 | MM15695 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 2.12e-04 | 94 | 182 | 7 | MM15598 | |
| Pathway | REACTOME_P75_NTR_RECEPTOR_MEDIATED_SIGNALLING | 2.57e-04 | 97 | 182 | 7 | M9400 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 2.73e-04 | 45 | 182 | 5 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 3.03e-04 | 46 | 182 | 5 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 3.36e-04 | 47 | 182 | 5 | M7946 | |
| Pathway | WP_IRINOTECAN_PATHWAY | 4.27e-04 | 12 | 182 | 3 | M39611 | |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | CYP8B1 UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.58e-04 | 219 | 182 | 10 | MM14838 |
| Pathway | REACTOME_BIOLOGICAL_OXIDATIONS | CYP8B1 UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.79e-04 | 220 | 182 | 10 | M10320 |
| Pathway | WP_2Q37_COPY_NUMBER_VARIATION_SYNDROME | 5.86e-04 | 145 | 182 | 8 | M45512 | |
| Pathway | WP_METAPATHWAY_BIOTRANSFORMATION_PHASE_I_AND_II | CYP8B1 UGT2A2 UGT1A10 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.20e-04 | 183 | 182 | 9 | M39588 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 6.45e-04 | 184 | 182 | 9 | M41809 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 6.63e-04 | 82 | 182 | 6 | M594 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 8.21e-04 | 33 | 182 | 4 | M604 | |
| Pathway | REACTOME_HEME_DEGRADATION | 8.59e-04 | 15 | 182 | 3 | M27060 | |
| Pathway | REACTOME_ATORVASTATIN_ADME | 8.59e-04 | 15 | 182 | 3 | MM15697 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 9.08e-04 | 155 | 182 | 8 | M41808 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 9.67e-04 | 59 | 182 | 5 | M11215 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 1.13e-03 | 61 | 182 | 5 | M39540 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 1.21e-03 | 92 | 182 | 6 | MM15338 | |
| Pathway | REACTOME_REGULATION_OF_TP53_ACTIVITY_THROUGH_PHOSPHORYLATION | 1.21e-03 | 92 | 182 | 6 | M27636 | |
| Pubmed | 3.22e-17 | 9 | 233 | 8 | 22511988 | ||
| Pubmed | 1.60e-16 | 10 | 233 | 8 | 23642732 | ||
| Pubmed | 1.60e-16 | 10 | 233 | 8 | 11465080 | ||
| Pubmed | 1.60e-16 | 10 | 233 | 8 | 23371916 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 1.60e-16 | 10 | 233 | 8 | 22558097 | |
| Pubmed | Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. | 5.53e-16 | 7 | 233 | 7 | 8467709 | |
| Pubmed | 5.53e-16 | 7 | 233 | 7 | 8464825 | ||
| Pubmed | 1.74e-15 | 12 | 233 | 8 | 19419973 | ||
| Pubmed | Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. | 1.74e-15 | 12 | 233 | 8 | 11434514 | |
| Pubmed | 4.40e-15 | 8 | 233 | 7 | 20610558 | ||
| Pubmed | 4.40e-15 | 8 | 233 | 7 | 17179145 | ||
| Pubmed | UGT1A1 is a major locus influencing bilirubin levels in African Americans. | 4.50e-15 | 13 | 233 | 8 | 22085899 | |
| Pubmed | Genome-wide analysis of hepatic lipid content in extreme obesity. | 4.50e-15 | 13 | 233 | 8 | 25246029 | |
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 21646302 | ||
| Pubmed | Human UDP-glucuronosyltransferases: metabolism, expression, and disease. | 1.04e-14 | 14 | 233 | 8 | 10836148 | |
| Pubmed | 1.04e-14 | 14 | 233 | 8 | 9295054 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.04e-14 | 14 | 233 | 8 | 14672974 | |
| Pubmed | Genome-wide association meta-analysis for total serum bilirubin levels. | 4.42e-14 | 16 | 233 | 8 | 19414484 | |
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 8.30e-14 | 17 | 233 | 8 | 20639394 | |
| Pubmed | A genome-wide assessment of variability in human serum metabolism. | 2.55e-13 | 19 | 233 | 8 | 23281178 | |
| Pubmed | Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans. | 4.26e-13 | 12 | 233 | 7 | 20308471 | |
| Pubmed | USP34 TRIM25 PSMA5 PSMB1 MCM7 CHD2 SSRP1 YTHDC1 GFPT1 WDR3 UBA1 NCAPG H4C1 NCAPD2 CDC73 ARIH1 NIPBL DNMT1 OGT ATG7 SMC6 NUMA1 BRD3 RFC3 RFC5 PBRM1 SBDS CTBP2 MYO15A CPSF3 TOP1 | 2.19e-12 | 1014 | 233 | 31 | 32416067 | |
| Pubmed | 2.35e-12 | 8 | 233 | 6 | 18052087 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 2.41e-12 | 24 | 233 | 8 | 24625756 | |
| Pubmed | 7.00e-12 | 9 | 233 | 6 | 1339448 | ||
| Pubmed | 1.29e-11 | 5 | 233 | 5 | 15057901 | ||
| Pubmed | Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. | 7.71e-11 | 6 | 233 | 5 | 19204906 | |
| Pubmed | 7.71e-11 | 6 | 233 | 5 | 20297805 | ||
| Pubmed | Discovery and refinement of loci associated with lipid levels. | F2 BRCA2 ATG7 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 APOB JMJD1C UGT1A4 UGT1A1 UGT1A3 TOP1 | 1.98e-10 | 211 | 233 | 14 | 24097068 |
| Pubmed | NOC2L MCM7 CHD2 SSRP1 YTHDC1 NCAPG NCAPD2 DNMT1 MAGED1 CECR2 NUMA1 MAGOHB BRD3 RFC3 KMT2D PBRM1 N4BP2 RBPJ INTS4 | 5.33e-10 | 469 | 233 | 19 | 27634302 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRIM25 NOC2L ACO2 PSMA5 PSMB1 MCM7 SSRP1 F2 GFPT1 WDR3 UBA1 NCAPG H4C1 CXCR4 NCAPD2 CDC73 NIPBL DNMT1 SMC6 NUMA1 APOB RFC3 RFC5 LDHB SACM1L PBRM1 MTOR NT5DC2 RBPJ HSD17B12 CTBP2 CPSF3 TOP1 | 5.85e-10 | 1425 | 233 | 33 | 30948266 |
| Pubmed | CYP8B1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.19e-10 | 66 | 233 | 9 | 19898482 | |
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 7.12e-10 | 8 | 233 | 5 | 12695355 | |
| Pubmed | MYO5A DOCK11 NOC2L PSMA5 PSMB1 MCF2L2 MCM7 CHN1 CHN2 CLCC1 UBA1 ARHGEF9 ARHGAP29 VAV1 FGD3 DOCK3 BIN1 MAGED1 TECR NUMA1 CNKSR2 LDHB OPHN1 ARHGEF10 CTBP2 CPSF3 | 7.21e-10 | 916 | 233 | 26 | 32203420 | |
| Pubmed | 1.47e-09 | 18 | 233 | 6 | 20056724 | ||
| Pubmed | Genetic variations and haplotypes of UDP-glucuronosyltransferase 1A locus in a Korean population. | 1.96e-09 | 4 | 233 | 4 | 18223459 | |
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 9535849 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 9271343 | ||
| Pubmed | 1.96e-09 | 4 | 233 | 4 | 17558305 | ||
| Pubmed | Human metabolic individuality in biomedical and pharmaceutical research. | 4.48e-09 | 57 | 233 | 8 | 21886157 | |
| Pubmed | USP34 MYO5A TRPM7 MCF2L2 MTMR10 GFPT1 WDR3 MIA2 KIF5A NIPBL PICK1 DNMT1 AKAP6 DOCK3 PPP4R1 SEMA4D BIN1 OGT MAGED1 WASHC4 KIF21A INTS8 ARHGEF10 TTC17 WDFY3 CTNND2 ZBTB11 TOP1 ECE2 | 1.26e-08 | 1285 | 233 | 29 | 35914814 | |
| Pubmed | 2.91e-08 | 6 | 233 | 4 | 32527940 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | TRIM25 MYO5A NOC2L ACO2 PSMA5 PSMB1 MCM7 CHD2 SSRP1 GFPT1 WDR3 UBA1 NCAPG H4C1 NCAPD2 ASPM NIPBL DNMT1 WASHC4 KIF21A NUMA1 RFC3 RFC5 LDHB SBDS CTBP2 WDFY3 CPSF3 TOP1 | 3.83e-08 | 1353 | 233 | 29 | 29467282 |
| Pubmed | 6.76e-08 | 7 | 233 | 4 | 27514509 | ||
| Pubmed | 1.35e-07 | 8 | 233 | 4 | 22579593 | ||
| Pubmed | Ten years on: mediation of cell death by the common neurotrophin receptor p75(NTR). | 1.58e-07 | 60 | 233 | 7 | 12787561 | |
| Pubmed | MYO5A DOCK11 ADGRB2 SLC12A5 TAOK2 UBA1 RABGEF1 KIF5A CDC73 NIPBL DNMT1 BIN1 OGT MAGED1 KIF21A NUMA1 CNKSR2 PBRM1 MTOR N4BP2 CTBP2 WDFY3 CTNND2 | 1.67e-07 | 963 | 233 | 23 | 28671696 | |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | CHD2 SSRP1 FSIP2 NIPBL DNMT1 OGT TECR SMC6 NUMA1 BRD3 RFC3 RFC5 JMJD1C PBRM1 TADA2B RBPJ ZBTB11 TOP1 | 1.83e-07 | 608 | 233 | 18 | 36089195 |
| Pubmed | 2.41e-07 | 9 | 233 | 4 | 11937492 | ||
| Pubmed | SIVA1 directs the E3 ubiquitin ligase RAD18 for PCNA monoubiquitination. | 2.41e-07 | 21 | 233 | 5 | 24958773 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 12051676 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 17097608 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 19364970 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 29519853 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 11179460 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 19303655 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 16636344 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 17406868 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 19996319 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 12847094 | ||
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 26247833 | ||
| Pubmed | Differences in UGT1A1, UGT1A7, and UGT1A9 polymorphisms between Uzbek and Japanese populations. | 2.97e-07 | 3 | 233 | 3 | 24453052 | |
| Pubmed | 2.97e-07 | 3 | 233 | 3 | 23789755 | ||
| Pubmed | TRIM25 PSMA5 MCM7 SSRP1 F2 YTHDC1 WDR3 NCAPG GLDC NCAPD2 DNMT1 KRT9 NUMA1 MAGOHB LDHB SBDS CTBP2 TOP1 | 3.95e-07 | 641 | 233 | 18 | 36057605 | |
| Pubmed | MYO1A MYO5A MYO5B NOC2L ACO2 CHD2 SSRP1 NEB MIA2 H4C1 NCAPD2 ASPM KIF5A NIPBL PICK1 SLC12A6 TECR KIF21A NUMA1 DNAH2 APOB BRD3 STK31 TRIM16 LATS2 N4BP2 ZBTB11 TOP1 | 4.96e-07 | 1442 | 233 | 28 | 35575683 | |
| Pubmed | 6.24e-07 | 11 | 233 | 4 | 18695635 | ||
| Pubmed | MAGOH UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 SNAI2 | 6.97e-07 | 190 | 233 | 10 | 24816252 | |
| Pubmed | 9.32e-07 | 12 | 233 | 4 | 18161889 | ||
| Pubmed | TTF-1/NKX2-1 binds to DDB1 and confers replication stress resistance to lung adenocarcinomas. | 9.52e-07 | 152 | 233 | 9 | 28192407 | |
| Pubmed | TRIM25 NOC2L SSRP1 UBA1 NCAPG H4C1 NCAPD2 SLC12A6 TECR LDHB SLC4A2 TMEM209 HSD17B12 TOP1 ATP6V0A2 | 1.13e-06 | 484 | 233 | 15 | 31995728 | |
| Pubmed | 1.18e-06 | 4 | 233 | 3 | 15855726 | ||
| Pubmed | Chromosomal mapping of a human phenol UDP-glucuronosyltransferase, GNT1. | 1.18e-06 | 4 | 233 | 3 | 2108603 | |
| Pubmed | 1.18e-06 | 4 | 233 | 3 | 8280139 | ||
| Pubmed | 1.18e-06 | 4 | 233 | 3 | 1634050 | ||
| Pubmed | 1.18e-06 | 4 | 233 | 3 | 8276413 | ||
| Pubmed | 1.18e-06 | 4 | 233 | 3 | 1898728 | ||
| Pubmed | 1.18e-06 | 4 | 233 | 3 | 20628391 | ||
| Pubmed | Early pancreatic islet fate and maturation is controlled through RBP-Jκ. | 1.18e-06 | 4 | 233 | 3 | 27240887 | |
| Pubmed | 1.18e-06 | 4 | 233 | 3 | 18665263 | ||
| Pubmed | 1.18e-06 | 4 | 233 | 3 | 10527805 | ||
| Pubmed | USP34 HAUS6 TRPM7 PSMA5 MCM7 CLCC1 WDR3 H4C1 DNMT1 KRT9 CCDC146 CEP162 SMC6 CNKSR2 APOB RFC3 LDHB EPB41 ATP6V0A2 | 1.47e-06 | 777 | 233 | 19 | 35844135 | |
| Pubmed | 1.86e-06 | 14 | 233 | 4 | 8022818 | ||
| Pubmed | 1.87e-06 | 55 | 233 | 6 | 27114453 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | USP34 PSMA5 PSMB1 MCM7 SSRP1 GFPT1 UBA1 NCAPG H4C1 NCAPD2 RABGEF1 CDC73 ARIH1 PPP4R1 BIN1 OGT WASHC4 ATG7 KIF21A RFC3 LDHB TRIM16 ARHGEF10 MTOR SBDS NCOA7 CTBP2 | 1.90e-06 | 1455 | 233 | 27 | 22863883 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | TRIM25 DOCK11 NOC2L MCM7 SSRP1 GFPT1 WDR3 H4C1 WEE1 NUMA1 RFC3 PBRM1 TMEM209 ZBTB11 | 1.90e-06 | 440 | 233 | 14 | 34244565 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | A2M MYO1A PSMA5 PSMB1 MCM7 GFPT1 UBA1 NCAPG NCAPD2 TECR RFC5 LDHB SACM1L MTOR XPNPEP3 HSD17B12 CTBP2 | 2.06e-06 | 647 | 233 | 17 | 26618866 |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | USP34 NOC2L PSMA5 MCM7 CHD2 YTHDC1 CLCC1 WDR3 MIA2 H4C1 NCAPD2 MAGED1 WASHC4 TECR SMC6 ZNF407 INTS8 JMJD1C SACM1L PBRM1 TMEM209 HSD17B12 CD151 TOP1 | 2.17e-06 | 1203 | 233 | 24 | 29180619 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOC2L CHD2 SSRP1 YTHDC1 WDR3 H4C1 CDC73 NIPBL DNMT1 OGT TECR NUMA1 MAGOHB BRD3 RFC3 RFC5 JMJD1C KMT2D PBRM1 TADA2B RBPJ TMEM209 INTS4 CPSF3 TOP1 | 2.32e-06 | 1294 | 233 | 25 | 30804502 |
| Pubmed | 2.94e-06 | 5 | 233 | 3 | 26010150 | ||
| Pubmed | 2.94e-06 | 5 | 233 | 3 | 20565459 | ||
| Pubmed | Pharmacokinetics of mycophenolate mofetil and its glucuronide metabolites in healthy volunteers. | 2.94e-06 | 5 | 233 | 3 | 18597651 | |
| Pubmed | 2.94e-06 | 5 | 233 | 3 | 10037471 | ||
| Pubmed | 2.94e-06 | 5 | 233 | 3 | 7677729 | ||
| Pubmed | 2.94e-06 | 5 | 233 | 3 | 22897852 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | NOC2L MCM7 CHD2 SSRP1 UBA1 NCAPG H4C1 OGT NUMA1 BRD3 RFC3 RFC5 PBRM1 | 3.00e-06 | 394 | 233 | 13 | 27248496 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOC2L ACO2 MCM7 CHD2 SSRP1 YTHDC1 WDR3 BLVRB NCAPG NIPBL DNMT1 KRT9 OGT ANK1 TECR NUMA1 MAGOHB RFC5 LDHB PBRM1 NT5DC2 HSD17B12 CTBP2 CPSF3 TOP1 | 3.20e-06 | 1318 | 233 | 25 | 30463901 |
| Pubmed | MAGOH TRIM25 MYO5A NOC2L CHD2 SSRP1 YTHDC1 TAOK2 WDR3 BLVRB ARHGEF9 NCAPD2 NIPBL OGT MAGED1 BRD3 RFC5 INTS8 HABP4 IFRD1 PBRM1 TADA2B CTBP2 CTNND2 ZBTB11 EPB41 ATP6V0A2 | 3.22e-06 | 1497 | 233 | 27 | 31527615 | |
| Pubmed | HAUS6 TRPM7 ACO2 ZNF236 GFPT1 CLCC1 UBA1 ASPM RABGEF1 NIPBL PPP4R1 OGT WEE1 TECR SMC6 LDHB SACM1L TRIM16 HABP4 PBRM1 SBDS TADA2B XPNPEP3 DEPDC5 ATP6V0A2 | 3.61e-06 | 1327 | 233 | 25 | 32694731 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | NOC2L CHD2 SSRP1 H4C1 NIPBL DNMT1 NUMA1 BRD3 RFC3 RFC5 PBRM1 CTBP2 TTC17 ZBTB11 TOP1 | 3.66e-06 | 533 | 233 | 15 | 30554943 |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | PSMA5 MCM7 SSRP1 TMEM200A WDR3 NCAPG H4C1 NCAPD2 KIF5A NIPBL DNMT1 KIF21A NUMA1 DNAH2 RFC5 LDHB PBRM1 SBDS TOP1 | 5.10e-06 | 847 | 233 | 19 | 35235311 |
| Interaction | POLB interactions | 1.43e-06 | 72 | 226 | 8 | int:POLB | |
| Interaction | WEE1 interactions | 2.61e-06 | 133 | 226 | 10 | int:WEE1 | |
| Interaction | SUZ12 interactions | MAGOH TRIM25 MCM7 CHD2 SSRP1 YTHDC1 NCAPG H4C1 GLDC NCAPD2 VAV1 DNMT1 CECR2 NUMA1 LDHB KMT2D PBRM1 LATS2 MTOR N4BP2 RBPJ TOP1 | 3.77e-06 | 644 | 226 | 22 | int:SUZ12 |
| Interaction | WWTR1 interactions | HAUS6 TRIM25 ERCC6L MCM7 SSRP1 UBA1 NCAPG H4C1 NCAPD2 DNMT1 OGT TECR NUMA1 JMJD1C KMT2D LATS2 EPB41 | 6.05e-06 | 422 | 226 | 17 | int:WWTR1 |
| Interaction | CTNNB1 interactions | TRIM25 PSEN1 PSEN2 MYO5B ACO2 PSMA5 MCM7 SSRP1 GFPT1 H4C1 GLDC ASPM CCNA1 CDC73 PICK1 DNMT1 FLT1 VEZT NUMA1 MAGOHB LDHB IFRD1 KMT2D LATS2 CTBP2 CTNND2 TOP1 CDH9 | 9.34e-06 | 1009 | 226 | 28 | int:CTNNB1 |
| Interaction | RABEP2 interactions | 9.92e-06 | 93 | 226 | 8 | int:RABEP2 | |
| Interaction | KDM4C interactions | 2.30e-05 | 76 | 226 | 7 | int:KDM4C | |
| Interaction | PNKP interactions | 2.47e-05 | 137 | 226 | 9 | int:PNKP | |
| Interaction | RCOR1 interactions | USP34 HAUS6 TRIM25 YTHDC1 NCAPG BRCA2 H4C1 NCAPD2 RABGEF1 OGT NUMA1 JMJD1C KMT2D RBPJ CTBP2 ZBTB11 ECE2 | 4.54e-05 | 494 | 226 | 17 | int:RCOR1 |
| Interaction | RAD23A interactions | A2M TRIM25 PSEN1 PSMA5 PSMB1 UBA1 BRCA2 H4C1 RABGEF1 OGT NT5DC3 | 4.76e-05 | 224 | 226 | 11 | int:RAD23A |
| Interaction | CPB2 interactions | 5.23e-05 | 19 | 226 | 4 | int:CPB2 | |
| Interaction | COIL interactions | MYO5B NOC2L PSMA5 MCM7 SSRP1 YTHDC1 WDR3 H4C1 NIPBL PICK1 OGT TECR BRD3 RFC5 PBRM1 HSD17B12 ZBTB11 TOP1 | 5.43e-05 | 552 | 226 | 18 | int:COIL |
| Interaction | WTAP interactions | 7.03e-05 | 194 | 226 | 10 | int:WTAP | |
| Interaction | RSF1 interactions | 7.97e-05 | 124 | 226 | 8 | int:RSF1 | |
| Interaction | RNF8 interactions | TRIM25 PSMA5 PSMB1 SSRP1 H4C1 PICK1 KRT9 MAGED1 RFC3 RFC5 LDHB JMJD1C PBRM1 TLR2 SNAI2 | 8.71e-05 | 421 | 226 | 15 | int:RNF8 |
| Interaction | POLA1 interactions | 8.92e-05 | 126 | 226 | 8 | int:POLA1 | |
| Interaction | MTA1 interactions | MAGEA11 TRIM25 SSRP1 PYHIN1 BRCA2 H4C1 PICK1 DNMT1 NUMA1 BRD3 CTBP2 TOP1 | 8.94e-05 | 283 | 226 | 12 | int:MTA1 |
| Interaction | ANAPC7 interactions | 9.16e-05 | 162 | 226 | 9 | int:ANAPC7 | |
| Interaction | CUL4A interactions | USP34 TRIM25 SSRP1 DCST1 ABCA10 GFPT1 PYHIN1 KLHL3 H4C1 GLDC ARIH1 DNMT1 KRT9 WASHC4 SMC6 NUMA1 ZNF407 NT5DC3 TRIM16 MTOR CTBP2 DEPDC5 TTC17 | 9.67e-05 | 854 | 226 | 23 | int:CUL4A |
| Cytoband | 2q37 | 2.78e-12 | 31 | 233 | 8 | 2q37 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q37 | 2.25e-05 | 226 | 233 | 8 | chr2q37 | |
| Cytoband | 7p15.3 | 4.28e-04 | 29 | 233 | 3 | 7p15.3 | |
| GeneFamily | UDP glucuronosyltransferases | UGT2A2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.97e-12 | 32 | 156 | 9 | 363 |
| GeneFamily | X-linked mental retardation|Rho GTPase activating proteins|BAR-PH domain containing | 1.16e-05 | 17 | 156 | 4 | 1291 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | AGAP5 DOCK11 AFAP1L1 ARHGEF9 VAV1 FGD3 PSD2 RASGRF1 CNKSR2 AGAP9 | 1.23e-05 | 206 | 156 | 10 | 682 |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.22e-05 | 66 | 156 | 6 | 722 | |
| GeneFamily | Myosins, class V | 2.21e-04 | 3 | 156 | 2 | 1100 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 9.02e-04 | 50 | 156 | 4 | 721 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 2.56e-03 | 9 | 156 | 2 | 1234 | |
| GeneFamily | ArfGAPs | 2.84e-03 | 33 | 156 | 3 | 395 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 3.18e-03 | 10 | 156 | 2 | 100 | |
| GeneFamily | WD repeat domain containing|F-box and WD repeat domain containing | 3.87e-03 | 11 | 156 | 2 | 559 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | HAUS6 ERCC6L NOC2L MCM7 ZRANB3 BLVRB NCAPG BRCA2 NCAPD2 ASPM DNMT1 MMS22L WEE1 RFC3 RFC5 LDHB SHQ1 FMNL3 NT5DC2 SERTAD4 CEP152 | 5.93e-08 | 578 | 233 | 21 | M2368 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | HAUS6 ERCC6L NOC2L MCM7 ZRANB3 BLVRB NCAPG BRCA2 NCAPD2 ASPM DNMT1 MMS22L WEE1 RFC3 RFC5 LDHB SHQ1 FMNL3 NT5DC2 SERTAD4 CEP152 | 1.02e-07 | 597 | 233 | 21 | MM1309 |
| Coexpression | FISCHER_DREAM_TARGETS | HAUS6 ERCC6L MCM7 SSRP1 ZRANB3 NCAPG BRCA2 H4C1 NCAPD2 ASPM NIPBL DNMT1 MMS22L WEE1 SMC6 MAGOHB RFC3 RFC5 TRIM45 IFRD1 PBRM1 IQCB1 TMEM209 CEP152 TOP1 | 2.00e-06 | 969 | 233 | 25 | M149 |
| Coexpression | LAZARO_GENETIC_MOUSE_MODEL_HIGH_GRADE_SMALL_CELL_NEUROENDOCRINE_LUNG_CARCINOMA_UP | RUNDC3B ADGRB2 MCM7 SSRP1 CHN2 ZRANB3 NCAPG PIGF BRCA2 NCAPD2 ASPM DNMT1 PDZD4 DOCK3 MMS22L MAGED1 RFC5 SERTAD4 CTNND2 | 1.20e-05 | 680 | 233 | 19 | MM456 |
| Coexpression | GSE32986_CURDLAN_HIGHDOSE_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP | PSEN1 ZRANB3 CHPT1 KIF5A DNMT1 SEMA4D PDPR DNAH2 OPHN1 CCNG2 | 1.25e-05 | 199 | 233 | 10 | M8636 |
| Coexpression | GSE27241_WT_CTRL_VS_DIGOXIN_TREATED_RORGT_KO_CD4_TCELL_IN_TH17_POLARIZING_CONDITIONS_UP | CYP8B1 GFPT1 ARHGAP29 RABGEF1 PDZD4 ANK1 JMJD1C FMNL3 FILIP1L | 2.49e-05 | 172 | 233 | 9 | M8234 |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_UP | 4.04e-05 | 183 | 233 | 9 | M2993 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C4_CYCLING_NK_CELL | HAUS6 MCM7 BLVRB NCAPG BRCA2 H4C1 NCAPD2 ASPM WEE1 SMC6 MAGOHB RFC3 RFC5 TIMM10 TMEM209 CTBP2 CEP152 CPSF3 | 5.39e-05 | 694 | 233 | 18 | M45767 |
| Coexpression | ZHOU_INFLAMMATORY_RESPONSE_FIMA_UP | ADCY10 RAPGEF5 CYP8B1 NEB TAOK2 KLHL3 NCAPD2 CCNA1 AGBL1 SEC14L4 IMPG2 SLC26A9 C5orf47 LIMK2 TLR2 | 6.67e-05 | 517 | 233 | 15 | M7140 |
| Coexpression | GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN | 7.08e-05 | 153 | 233 | 8 | M350 | |
| Coexpression | GSE28130_ACTIVATED_VS_INDUCEED_TREG_UP | 7.16e-05 | 197 | 233 | 9 | M8343 | |
| Coexpression | PKCA_DN.V1_DN | 7.41e-05 | 154 | 233 | 8 | M2754 | |
| Coexpression | GSE27859_DC_VS_CD11C_INT_F480_INT_DC_DN | 8.04e-05 | 200 | 233 | 9 | M8600 | |
| Coexpression | HALLMARK_E2F_TARGETS | 8.04e-05 | 200 | 233 | 9 | M5925 | |
| Coexpression | GSE40274_CTRL_VS_FOXP3_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 8.04e-05 | 200 | 233 | 9 | M9135 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | HAUS6 MYO5B DOCK11 NCAPG MIA2 BRCA2 GLDC ASPM NIPBL DNMT1 KIF21A SMC6 RWDD3 IFRD1 N4BP2 CTNND2 TOP1 EPB41 | 1.51e-05 | 532 | 224 | 18 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.04e-05 | 115 | 224 | 8 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | ERCC6L RUNDC3B NCAPG BRCA2 GLDC MOV10L1 CPLANE1 DOCK3 MMS22L CECR2 CNKSR2 STK31 IQCB1 RNF212B | 6.38e-05 | 385 | 224 | 14 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | USP34 MAGEA11 MYO5A RUNDC3B DOCK11 MCM7 CHD2 NCAPG BRCA2 MOV10L1 ARHGAP29 CPLANE1 PDPR TECR SMC6 STK31 JMJD1C C5orf47 IQCB1 DEPDC5 TOP1 | 7.93e-05 | 776 | 224 | 21 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 8.12e-05 | 98 | 224 | 7 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | MAGEA11 ERCC6L MCM7 ZRANB3 NCAPG NCAPD2 MMS22L WEE1 CECR2 RFC5 GNA14 | 9.84e-05 | 258 | 224 | 11 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k2_1000 |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | MYO5A DOCK11 NCAPG BRCA2 KCNE1 ASPM VAV1 FGD3 ATG7 TLR2 RBPJ NCKAP1L | 4.55e-10 | 192 | 233 | 12 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M MYO7B ABCA13 NEB PIK3C2G KIF5A GALNTL6 ANK1 CNKSR2 APOB MYO15A | 3.91e-09 | 184 | 233 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M MYO7B ABCA13 NEB PIK3C2G KIF5A GALNTL6 ANK1 CNKSR2 APOB MYO15A | 3.91e-09 | 184 | 233 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | A2M MYO7B ABCA13 NEB PIK3C2G KIF5A GALNTL6 ANK1 CNKSR2 APOB MYO15A | 3.91e-09 | 184 | 233 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | RV-08._Macrophage|RV / Chamber and Cluster_Paper | 7.80e-08 | 193 | 233 | 10 | 12bf98a280f87e4d8f0c6887dfc855da72e47ac1 | |
| ToppCell | LA-08._Macrophage|World / Chamber and Cluster_Paper | 8.19e-08 | 194 | 233 | 10 | c1805572bcc11b1cd29083329d7b5911489fb758 | |
| ToppCell | PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.06e-07 | 163 | 233 | 9 | 7af3d3ae7e0de733a18d0486c7ffbb5a7ef7230a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | NCAPG BRCA2 C5 EEF1AKMT4-ECE2 MMS22L UGT1A8 MAGOHB RFC5 HES5 | 2.79e-07 | 169 | 233 | 9 | 121768fc51fc3441ec725346a1bbe29e21d05971 |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-enterocyte_of_epithelium_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-07 | 176 | 233 | 9 | 7622f5a8e7320cc7b593141854107ecaf4adff7f | |
| ToppCell | IIH-Treg-proli_CD4|IIH / Condition, Cell_class and T cell subcluster | 5.22e-07 | 182 | 233 | 9 | 5c7d02da9ca2bca49db9832704b6894dfaa08a71 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.84e-07 | 188 | 233 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.84e-07 | 188 | 233 | 9 | 0476d7ee3e0ce78c3c5b111e9ade01098f9ea7ec | |
| ToppCell | LV-08._Macrophage|World / Chamber and Cluster_Paper | 7.81e-07 | 191 | 233 | 9 | e7a0bc46ba9ba772636a583f3387748418e18832 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.16e-07 | 192 | 233 | 9 | e8d47504b744040a762ec9b670a66cc060b2ae86 | |
| ToppCell | LA-08._Macrophage|LA / Chamber and Cluster_Paper | 9.28e-07 | 195 | 233 | 9 | 5e1d5bdb8874091f5a2b1d0a8cc9008165718a97 | |
| ToppCell | Healthy-T/NK_proliferative|World / disease group, cell group and cell class | 1.01e-06 | 197 | 233 | 9 | e90be1e7e02f736b6aab14010a912b592d6f1e80 | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Severe / Disease group, lineage and cell class | 1.10e-06 | 199 | 233 | 9 | ddae7fe7633661f15d3c79f5187415ffbfecce67 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.15e-06 | 200 | 233 | 9 | be83f442179ba4217d12f0458059586ff3130991 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells-Neuroepithelial_cell|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.15e-06 | 200 | 233 | 9 | 8f8b8c225cdc79baf16fe04be89bdb65e404a055 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-10w-Stem_cells|10w / Sample Type, Dataset, Time_group, and Cell type. | 1.15e-06 | 200 | 233 | 9 | a1f48eca9efb4f3ec3c9ace20f8c9257dd72c4ed | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Severe / Disease, condition lineage and cell class | 1.15e-06 | 200 | 233 | 9 | 0892603e604c2a945dd720685d45970f855bd5d3 | |
| ToppCell | mild-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.15e-06 | 200 | 233 | 9 | 63cc57b9331459efbb73051d174d198a3568b938 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.18e-06 | 161 | 233 | 8 | bf70be1de418615b5442ec684552551edaf1f072 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.28e-06 | 162 | 233 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.39e-06 | 163 | 233 | 8 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-06 | 166 | 233 | 8 | 8d0c4eb90a2c006f96ae61d3d94c96fb64bc0c4d | |
| ToppCell | facs-Kidney-nan-3m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.74e-06 | 166 | 233 | 8 | 6a948aefd283a2572da37b59dbc142b6e686b024 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.86e-06 | 167 | 233 | 8 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cells|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 168 | 233 | 8 | e8878ec68b21c8d5694d7209b816d2f869673164 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Myeloid-plasmacytoid_dendritic_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-06 | 168 | 233 | 8 | a007758c219d3d5db2b5529f29af63be0d408304 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-capillary_endothelial_cell-EC_general_capillary-EC_general_capillary_L.2.0.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.13e-06 | 169 | 233 | 8 | 0d8b681404e18f3061d84425fb5f7d84e8e2b8d7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.13e-06 | 169 | 233 | 8 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.27e-06 | 170 | 233 | 8 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Enterocyte_(Proximal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-06 | 171 | 233 | 8 | 5d0d6c1ff610a703ae0b834a12823c5ff9012932 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-Treg-Treg_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.05e-06 | 175 | 233 | 8 | 9de288c338cee67be0e9b836c87799bbc1db1c38 | |
| ToppCell | COVID-19-kidney-Stressed_EC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.79e-06 | 179 | 233 | 8 | 754f69bac7a1d5137f5141f6193285ccbfe361cb | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.79e-06 | 179 | 233 | 8 | 54621d2b3a66e62aa76b7e444118878ed97c1e02 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.99e-06 | 180 | 233 | 8 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 4.99e-06 | 180 | 233 | 8 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 4.99e-06 | 180 | 233 | 8 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.86e-06 | 184 | 233 | 8 | 23515c28e1f42aab29cef9e5b4a7f45bda7f5520 | |
| ToppCell | COVID-19-Endothelial_cells-Systemic_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 6.10e-06 | 185 | 233 | 8 | f5e14181f45c37d13ee9e017a4c8bc248c353676 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Papillary_Renal_Cell_Carcinoma-9|TCGA-Kidney / Sample_Type by Project: Shred V9 | 6.21e-06 | 132 | 233 | 7 | f1ef63a4842ab6ca584a9dcc2dd5b2108fc990aa | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|World / Chamber and Cluster_Paper | 6.60e-06 | 187 | 233 | 8 | 78cdcf8bc141d3b155c3c8af908431fc419c4d08 | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD79a_B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.60e-06 | 187 | 233 | 8 | b51af2824e65734f333b1325117f4a2e88b17c23 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.60e-06 | 187 | 233 | 8 | e3095455d2f255854f339f6b05fa87852af0700f | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-leukocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.86e-06 | 188 | 233 | 8 | 61b6047affa18c5e71210fcce449e2bbe7cf141b | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.86e-06 | 188 | 233 | 8 | 797ce39602f0f78081eb44a21da0d9443f7fd9cf | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | 7.13e-06 | 189 | 233 | 8 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.13e-06 | 189 | 233 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | pdx-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 7.41e-06 | 190 | 233 | 8 | d06ee5f89f1cec8db6897fe3b2a890a07cd3697b | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.41e-06 | 190 | 233 | 8 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.70e-06 | 191 | 233 | 8 | 318323a12029a7992f16382cb0c186f5b2e1ca47 | |
| ToppCell | E17.5-Epithelial-epithelial_progenitor_cell-epi_progenitor|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 7.70e-06 | 191 | 233 | 8 | 328b98d371a7d6b6a1adc61ded05a3e52a839894 | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.70e-06 | 191 | 233 | 8 | 4aa29337f4d2528577bb90dc4abfb6eab93e120f | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.70e-06 | 191 | 233 | 8 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | LV-08._Macrophage|LV / Chamber and Cluster_Paper | 8.00e-06 | 192 | 233 | 8 | 7be12d580aaf2f2f1562203fcad3a44639b8c5a6 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.00e-06 | 192 | 233 | 8 | 28eb3a5728e8901bcb5ba12f6b009f41b065fa37 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.00e-06 | 192 | 233 | 8 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 8.31e-06 | 193 | 233 | 8 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.31e-06 | 193 | 233 | 8 | 7261c1ce30c796b61c6ec58e64a051baa24732ff | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.31e-06 | 193 | 233 | 8 | 40eedc1490c113403bc7c12a6bdf976f4f8bca84 | |
| ToppCell | COVID-19-Heart-Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 8.63e-06 | 194 | 233 | 8 | f09675cd472200363c458952f00d2e41990800ee | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.63e-06 | 194 | 233 | 8 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.63e-06 | 194 | 233 | 8 | 11709704079f24a730476572dc2f01e9d2226e2c | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.63e-06 | 194 | 233 | 8 | 3a1f95639d5f239f001bd67d4213e8938e7f299d | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.63e-06 | 194 | 233 | 8 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 8.96e-06 | 195 | 233 | 8 | b65463a804fed2d9a3be9e528ca8b9c98469bc86 | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-06 | 195 | 233 | 8 | 043e2f19d95e94cd5219e2c415f322ed340aa80f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 8.96e-06 | 195 | 233 | 8 | cec7df321f372d05c94f97d6bb18891a5cc3dec3 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.96e-06 | 195 | 233 | 8 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 8.96e-06 | 195 | 233 | 8 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.96e-06 | 195 | 233 | 8 | 56d8734d020b3da08a5aa9e67999706a9e023a99 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-06 | 196 | 233 | 8 | 8ad8efb631164b46f0c082572270188e5ead20bf | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 9.30e-06 | 196 | 233 | 8 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.30e-06 | 196 | 233 | 8 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.30e-06 | 196 | 233 | 8 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 9.30e-06 | 196 | 233 | 8 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.30e-06 | 196 | 233 | 8 | 9606ea7e42f707e69ea891b3521037613b9675f5 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.65e-06 | 197 | 233 | 8 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.65e-06 | 197 | 233 | 8 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.65e-06 | 197 | 233 | 8 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.00e-05 | 198 | 233 | 8 | af4fb9eb2295c7b90624b38ba25619aa15254efa | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.00e-05 | 198 | 233 | 8 | ad39cce004867f083f8da1954e0cf5a263815184 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-05 | 198 | 233 | 8 | 953630dbe3154b1b102b87de0feca2cbf124eabe | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.00e-05 | 198 | 233 | 8 | 62cbf4b29e8af4983fb47a17f96da62682a5137e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-05 | 198 | 233 | 8 | 8e45551224fbb30c0658ad47dd98335ecf165437 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-05 | 199 | 233 | 8 | e98ff036d04fc78dffef156bdc0d644532274067 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.04e-05 | 199 | 233 | 8 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Proliferating-Cycling_Progenitors|6_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.04e-05 | 199 | 233 | 8 | a99516a5760f49a69b0fe45a9b2316e393252966 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 199 | 233 | 8 | 88d130e2451e61afb710edf552e6b346b9fcfb2b | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.04e-05 | 199 | 233 | 8 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.04e-05 | 199 | 233 | 8 | 7feedb0bf84a3361c8ab5b6674ff64e8ff140c23 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-05 | 199 | 233 | 8 | 123fbf2122aa221d8cbf3aef9361ba0982c07695 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-05 | 199 | 233 | 8 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.04e-05 | 199 | 233 | 8 | 6b1304417cf9c44ca70d2bfc2b5acc1a206f25b6 | |
| ToppCell | Frontal_cortex-Neuronal|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.04e-05 | 199 | 233 | 8 | f88039d862f3bfa01dc39d2de4f3f548dc5a0e61 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-FOXM1|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.04e-05 | 199 | 233 | 8 | be2276c9a1994579ba1d2998b49bf549c1324d44 | |
| ToppCell | myeloid-pro-cDC|myeloid / Lineage and Cell class | 1.08e-05 | 200 | 233 | 8 | 4aa2308eeb94e0bdff4e02eb9e45ba8837ae14bf | |
| ToppCell | Neuronal-Inhibitory-iA-iA_3(VIP)-VIP_3|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.08e-05 | 200 | 233 | 8 | 7e51715525fdb001b7042b2bfcb9de81ecb5e4ee | |
| Drug | AC1MRQNQ | 8.57e-16 | 9 | 230 | 8 | CID003522271 | |
| Drug | DHPASiU | 8.57e-16 | 9 | 230 | 8 | CID000197602 | |
| Drug | 3-iodophenol | 8.57e-16 | 9 | 230 | 8 | CID000012272 | |
| Drug | AC1L4J7U | 8.57e-16 | 9 | 230 | 8 | CID000186631 | |
| Drug | Chebi:32663 | 8.57e-16 | 9 | 230 | 8 | CID005460873 | |
| Drug | afloqualone | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 SBDS | 4.45e-15 | 15 | 230 | 9 | CID000002040 |
| Drug | 4-nitrophenyl)imidazole | 1.54e-14 | 11 | 230 | 8 | CID000123155 | |
| Drug | AC1O5XMV | 1.54e-14 | 11 | 230 | 8 | CID006442661 | |
| Drug | retigabine | TRIM25 CHN1 KCNE1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 TECR UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 4.28e-14 | 48 | 230 | 12 | CID000121892 |
| Drug | N-OH-DABZ | 4.59e-14 | 12 | 230 | 8 | CID000051366 | |
| Drug | 1-O-beta-D-glucopyranosyl-D-mannitol | 4.59e-14 | 12 | 230 | 8 | CID000088735 | |
| Drug | 2,4,6-TCB | 4.59e-14 | 12 | 230 | 8 | CID000037247 | |
| Drug | nonanoyl-N-methylglucamide | 4.59e-14 | 12 | 230 | 8 | CID000160090 | |
| Drug | 7,7,7-triphenylheptanoic acid | 4.59e-14 | 12 | 230 | 8 | CID000276709 | |
| Drug | tritanol | 1.18e-13 | 13 | 230 | 8 | CID000006457 | |
| Drug | 5-azido-UDP-glucuronic acid | 1.18e-13 | 13 | 230 | 8 | CID003081279 | |
| Drug | cotinine-N-glucuronide | 1.18e-13 | 13 | 230 | 8 | CID000000411 | |
| Drug | propranolol glucuronide | 2.74e-13 | 14 | 230 | 8 | CID000119515 | |
| Drug | PCB-61 | 2.74e-13 | 14 | 230 | 8 | CID000036401 | |
| Drug | amonafide | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 TOP1 | 4.16e-13 | 22 | 230 | 9 | CID000050515 |
| Drug | 2,2',3,5,5'-pentachlorobiphenyl | 5.81e-13 | 15 | 230 | 8 | CID000040469 | |
| Drug | naphthyl sulphate | 5.81e-13 | 15 | 230 | 8 | CID000114775 | |
| Drug | coumarin-3-carboxylic acid | 5.81e-13 | 15 | 230 | 8 | CID000010752 | |
| Drug | sulforaphane nitrile | 5.81e-13 | 15 | 230 | 8 | CID000543743 | |
| Drug | AS-3201 | ARIH1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.07e-12 | 24 | 230 | 9 | CID000153948 |
| Drug | quercetin-3,4'-diglucoside | 1.15e-12 | 16 | 230 | 8 | CID005320835 | |
| Drug | 1'-hydroxyestragole | 1.15e-12 | 16 | 230 | 8 | CID000040003 | |
| Drug | bilirubin-phosphate | 1.15e-12 | 16 | 230 | 8 | CID005497144 | |
| Drug | 3 beta,5 alpha,25R)- 3-hydroxyspirostan-12-one | 2.16e-12 | 17 | 230 | 8 | CID000003573 | |
| Drug | 6-hydroxychrysene | 2.16e-12 | 17 | 230 | 8 | CID000037766 | |
| Drug | niflumic acid | F2 CLCC1 SLC12A6 SLC26A3 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 SLC26A9 UGT1A4 UGT1A1 UGT1A3 SLC9A2 CD151 | 2.50e-12 | 125 | 230 | 15 | CID000004488 |
| Drug | SureCN12722713 | 3.85e-12 | 18 | 230 | 8 | CID005488034 | |
| Drug | ethyl-beta-D-6-glucosiduronic acid | 3.85e-12 | 18 | 230 | 8 | CID000152226 | |
| Drug | Br 2 | 3.85e-12 | 18 | 230 | 8 | CID003060900 | |
| Drug | 2,3,7-trichlorodibenzo-p-dioxin | 3.85e-12 | 18 | 230 | 8 | CID000036614 | |
| Drug | ApApG | 3.85e-12 | 18 | 230 | 8 | CID003081975 | |
| Drug | C1 11-32 | 3.85e-12 | 18 | 230 | 8 | CID000443077 | |
| Drug | C11131 | 3.85e-12 | 18 | 230 | 8 | CID000443076 | |
| Drug | N-hydroxy-4-aminobiphenyl | DOCK3 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.47e-12 | 28 | 230 | 9 | CID000081261 |
| Drug | 9-OH-risperidone | 6.59e-12 | 19 | 230 | 8 | CID000475100 | |
| Drug | 5alpha-spirostan-3beta-ol | 6.59e-12 | 19 | 230 | 8 | CID000091433 | |
| Drug | almokalant | 6.59e-12 | 19 | 230 | 8 | CID003033962 | |
| Drug | AC1L1JAL | GFPT1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 7.87e-12 | 29 | 230 | 9 | CID000004954 |
| Drug | iberin | 7.87e-12 | 29 | 230 | 9 | CID000010455 | |
| Drug | tectochrysin | 1.09e-11 | 20 | 230 | 8 | CID005281954 | |
| Drug | AC1L1OBF | 1.09e-11 | 20 | 230 | 8 | CID000032736 | |
| Drug | 4'-hydroxydiclofenac | 1.09e-11 | 20 | 230 | 8 | CID000116545 | |
| Drug | paricalcitol | 1.11e-11 | 30 | 230 | 9 | CID005281104 | |
| Drug | estriol-16-glucuronide | 1.74e-11 | 21 | 230 | 8 | CID000122281 | |
| Drug | dulcin | 1.74e-11 | 21 | 230 | 8 | CID000009013 | |
| Drug | Benzamidoxime hydrochloride | 1.74e-11 | 21 | 230 | 8 | CID000069186 | |
| Drug | N-methylpiperazine | 2.72e-11 | 22 | 230 | 8 | CID000053167 | |
| Drug | norbuprenorphine | ACO2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.93e-11 | 33 | 230 | 9 | CID000114976 |
| Drug | geniposide | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 TOP1 | 2.93e-11 | 33 | 230 | 9 | CID000107848 |
| Drug | estragole | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 MTOR | 3.94e-11 | 34 | 230 | 9 | CID000008815 |
| Drug | amidoxime | 4.13e-11 | 23 | 230 | 8 | CID000465967 | |
| Drug | estradiol-3-glucuronide | 4.13e-11 | 23 | 230 | 8 | CID000066651 | |
| Drug | phenanthridine | 4.13e-11 | 23 | 230 | 8 | CID000009189 | |
| Drug | EM-652 | TRIM25 MCM7 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 5.30e-11 | 49 | 230 | 10 | CID000155435 |
| Drug | campestrol | CYP8B1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 APOB UGT1A4 UGT1A1 UGT1A3 | 5.30e-11 | 49 | 230 | 10 | CID000010134 |
| Drug | muraglitazar | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 APOB UGT1A4 UGT1A1 UGT1A3 | 6.96e-11 | 36 | 230 | 9 | CID000206044 |
| Drug | anisole | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 ATP6V0A2 | 6.96e-11 | 36 | 230 | 9 | CID000007519 |
| Drug | bevirimat | CXCR4 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 6.96e-11 | 36 | 230 | 9 | CID000457928 |
| Drug | 5-MOP | 8.96e-11 | 25 | 230 | 8 | CID000002355 | |
| Drug | AzMC | 8.96e-11 | 25 | 230 | 8 | CID000064986 | |
| Drug | N-acetylbenzidine | 8.96e-11 | 25 | 230 | 8 | CID000018787 | |
| Drug | 5,6-benzoquinoline | 8.96e-11 | 25 | 230 | 8 | CID000006796 | |
| Drug | N-phenylmaleimide | 8.96e-11 | 25 | 230 | 8 | CID000013662 | |
| Drug | N-Fg | ARIH1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 9.11e-11 | 37 | 230 | 9 | CID000445227 |
| Drug | 8-prenylnaringenin | TRIM25 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 TOP1 | 9.93e-11 | 52 | 230 | 10 | CID000480764 |
| Drug | naringenin chalcone | 1.01e-10 | 5 | 230 | 5 | ctd:C027329 | |
| Drug | anthrarobin | 1.01e-10 | 5 | 230 | 5 | ctd:C032186 | |
| Drug | nitrosamine | CHRNA5 KRT9 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 PBRM1 | 1.13e-10 | 70 | 230 | 11 | CID000037183 |
| Drug | x Me | BRCA2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.18e-10 | 38 | 230 | 9 | CID009600424 |
| Drug | diflunisal | 1.81e-10 | 27 | 230 | 8 | CID000003059 | |
| Drug | DiMeIQx | 1.81e-10 | 27 | 230 | 8 | CID000104739 | |
| Drug | thymoquinone | ACO2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 1.95e-10 | 40 | 230 | 9 | CID000010281 |
| Drug | AC1Q6O8B | CYP8B1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 | 2.48e-10 | 41 | 230 | 9 | CID000000334 |
| Drug | CARMINE | 2.51e-10 | 28 | 230 | 8 | CID000014749 | |
| Drug | erucin | 2.51e-10 | 28 | 230 | 8 | CID000078160 | |
| Drug | H-Ni | 2.51e-10 | 28 | 230 | 8 | CID000445665 | |
| Drug | L 654969 | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 APOB UGT1A4 UGT1A1 UGT1A3 | 3.13e-10 | 42 | 230 | 9 | CID000005218 |
| Drug | 7-hydroxycoumarin glucuronide | 3.43e-10 | 29 | 230 | 8 | CID000125641 | |
| Drug | 7-hydroxy-4-trifluoromethylcoumarin | 3.43e-10 | 29 | 230 | 8 | CID005375667 | |
| Drug | trans-3'-hydroxycotinine | 3.43e-10 | 29 | 230 | 8 | CID000000414 | |
| Drug | Woodward's reagent K | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 SLC4A2 UGT1A4 UGT1A1 UGT1A3 | 3.92e-10 | 43 | 230 | 9 | CID000077804 |
| Drug | androsterone glucuronide | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 APOB UGT1A4 UGT1A1 UGT1A3 | 3.92e-10 | 43 | 230 | 9 | CID000114833 |
| Drug | 7,8-benzoquinoline | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 SLC4A2 UGT1A4 UGT1A1 UGT1A3 | 3.92e-10 | 43 | 230 | 9 | CID000009191 |
| Drug | tolcapone | 4.64e-10 | 30 | 230 | 8 | CID004659569 | |
| Drug | AC1L9E0Q | 4.64e-10 | 30 | 230 | 8 | CID000443095 | |
| Drug | dihydroartemisinin | 4.64e-10 | 30 | 230 | 8 | CID000107770 | |
| Drug | anthraflavic acid | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 APOB UGT1A4 UGT1A1 UGT1A3 | 4.88e-10 | 44 | 230 | 9 | CID000006776 |
| Drug | MS-222 | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 UGT1A4 UGT1A1 UGT1A3 TOP1 | 4.88e-10 | 44 | 230 | 9 | CID000011400 |
| Drug | 1,2,5,8-tetrahydroxy anthraquinone | 5.99e-10 | 6 | 230 | 5 | ctd:C543211 | |
| Drug | alloin | 5.99e-10 | 6 | 230 | 5 | ctd:C006457 | |
| Drug | 2',5'-dihydroxychalcone | 5.99e-10 | 6 | 230 | 5 | ctd:C107497 | |
| Drug | PCB 156 | 6.20e-10 | 31 | 230 | 8 | CID000038019 | |
| Drug | 4'-HPPH | 6.20e-10 | 31 | 230 | 8 | CID000017732 | |
| Drug | 4-ethylphenol | 6.20e-10 | 31 | 230 | 8 | CID000031242 | |
| Drug | Muracein C | 8.20e-10 | 32 | 230 | 8 | CID003086323 | |
| Disease | X-11442 measurement | 9.02e-17 | 9 | 225 | 8 | EFO_0021236 | |
| Disease | X-11441 measurement | 9.02e-17 | 9 | 225 | 8 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 9.02e-17 | 9 | 225 | 8 | EFO_0004739 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 9.02e-17 | 9 | 225 | 8 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 4.48e-16 | 10 | 225 | 8 | EFO_0004570, EFO_0009279 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 4.48e-16 | 10 | 225 | 8 | EFO_0802185 | |
| Disease | histidine betaine (hercynine) measurement | 1.63e-15 | 11 | 225 | 8 | EFO_0800972 | |
| Disease | X-21796 measurement | 1.63e-15 | 11 | 225 | 8 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 1.63e-15 | 11 | 225 | 8 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 1.63e-15 | 11 | 225 | 8 | EFO_0010219 | |
| Disease | biliverdin measurement | 4.86e-15 | 12 | 225 | 8 | EFO_0021033 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.09e-14 | 8 | 225 | 7 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.09e-14 | 8 | 225 | 7 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.09e-14 | 8 | 225 | 7 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.09e-14 | 8 | 225 | 7 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.09e-14 | 8 | 225 | 7 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.09e-14 | 8 | 225 | 7 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.09e-14 | 8 | 225 | 7 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.09e-14 | 8 | 225 | 7 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.09e-14 | 8 | 225 | 7 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.09e-14 | 8 | 225 | 7 | EFO_0800766 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 4.85e-14 | 9 | 225 | 7 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 4.85e-14 | 9 | 225 | 7 | EFO_0801036 | |
| Disease | X-11880 measurement | 4.85e-14 | 9 | 225 | 7 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 4.85e-14 | 9 | 225 | 7 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 4.85e-14 | 9 | 225 | 7 | EFO_0802127 | |
| Disease | X-21448 measurement | 1.61e-13 | 10 | 225 | 7 | EFO_0800816 | |
| Disease | X-23974 measurement | 1.61e-13 | 10 | 225 | 7 | EFO_0800867 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 2.31e-13 | 17 | 225 | 8 | EFO_0004611, EFO_0007800 | |
| Disease | p-cresol glucuronide measurement | 1.05e-12 | 12 | 225 | 7 | EFO_0800079 | |
| Disease | tissue factor measurement | 1.89e-12 | 21 | 225 | 8 | EFO_0010623 | |
| Disease | retinol dehydrogenase 16 measurement | 2.25e-12 | 13 | 225 | 7 | EFO_0802007 | |
| Disease | xanthurenate measurement | 3.77e-11 | 29 | 225 | 8 | EFO_0010551 | |
| Disease | angiopoietin-related protein 1 measurement | 4.05e-11 | 18 | 225 | 7 | EFO_0801382 | |
| Disease | response to dolutegravir | 5.11e-11 | 30 | 225 | 8 | EFO_0600017 | |
| Disease | pregnenetriol sulfate measurement | 8.23e-11 | 11 | 225 | 6 | EFO_0800586 | |
| Disease | plasma N-desmethylclozapine measurement | 8.23e-11 | 11 | 225 | 6 | EFO_0600039 | |
| Disease | pregnenetriol disulfate measurement | 3.02e-10 | 13 | 225 | 6 | EFO_0800587 | |
| Disease | serum N-desmethylclozapine measurement | 1.36e-09 | 8 | 225 | 5 | EFO_0600043 | |
| Disease | plasma clozapine measurement | 1.36e-09 | 8 | 225 | 5 | EFO_0600038 | |
| Disease | X-21441 measurement | 2.12e-09 | 17 | 225 | 6 | EFO_0800814 | |
| Disease | urate measurement, spine bone mineral density | 1.39e-08 | 58 | 225 | 8 | EFO_0004531, EFO_0007701 | |
| Disease | N-acetyl-4-chlorophenylalanine measurement | 1.64e-08 | 5 | 225 | 4 | EFO_0801060 | |
| Disease | 5-hydroxyindole sulfate measurement | 1.64e-08 | 5 | 225 | 4 | EFO_0800085 | |
| Disease | nuclear receptor subfamily 1 group D member 2 measurement | 1.64e-08 | 5 | 225 | 4 | EFO_0801853 | |
| Disease | cholelithiasis | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 JMJD1C UGT1A4 UGT1A1 UGT1A3 | 2.52e-08 | 88 | 225 | 9 | EFO_0004799 |
| Disease | X-21339 measurement | 1.13e-07 | 7 | 225 | 4 | EFO_0800808 | |
| Disease | gallstones | UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 JMJD1C UGT1A4 UGT1A1 UGT1A3 | 1.51e-07 | 108 | 225 | 9 | EFO_0004210 |
| Disease | vitamin D deficiency | 3.51e-07 | 37 | 225 | 6 | EFO_0003762 | |
| Disease | indole-3-carboxylate measurement | 4.38e-07 | 3 | 225 | 3 | EFO_0800043 | |
| Disease | blood 4-oxo-retinoic acid measurement | 4.38e-07 | 3 | 225 | 3 | EFO_0022216 | |
| Disease | Malignant neoplasm of breast | ACO2 MCF2L2 MIA2 BRCA2 H4C1 CXCR4 ARHGAP29 NIPBL DNMT1 PDZD4 AKAP6 FLT1 ANK1 SMC6 MAGOHB UGT1A9 LDHB SLC9A2 KMT2D PBRM1 MTOR N4BP2 SNAI2 CPSF3 TOP1 | 8.08e-07 | 1074 | 225 | 25 | C0006142 |
| Disease | bilirubin measurement | BLVRB ANK1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 ZNF407 APOB LDHB JMJD1C UGT1A4 UGT1A1 UGT1A3 TOP1 | 1.76e-06 | 442 | 225 | 15 | EFO_0004570 |
| Disease | vitamin D measurement, COVID-19 | 1.96e-06 | 49 | 225 | 6 | EFO_0004631, MONDO_0100096 | |
| Disease | neuroblastoma, cutaneous melanoma | 2.10e-06 | 28 | 225 | 5 | EFO_0000389, EFO_0000621 | |
| Disease | thyroxine measurement | 3.47e-06 | 83 | 225 | 7 | EFO_0005130 | |
| Disease | hormone measurement | 3.76e-06 | 84 | 225 | 7 | EFO_0004730 | |
| Disease | apolipoprotein B measurement | PSEN1 PSMA5 ABCA10 CLCC1 NCAPG BRCA2 CXCR4 ANK1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 APOB UGT1A4 UGT1A3 XPNPEP3 TOP1 | 3.84e-06 | 663 | 225 | 18 | EFO_0004615 |
| Disease | 3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) measurement | 8.60e-06 | 6 | 225 | 3 | EFO_0800566 | |
| Disease | cerebral palsy (implicated_via_orthology) | 5.05e-05 | 10 | 225 | 3 | DOID:1969 (implicated_via_orthology) | |
| Disease | indoleacetate measurement | 5.05e-05 | 10 | 225 | 3 | EFO_0021015 | |
| Disease | mucoepidermoid carcinoma (is_marker_for) | 5.79e-05 | 2 | 225 | 2 | DOID:4531 (is_marker_for) | |
| Disease | Alzheimer's disease 3 (implicated_via_orthology) | 5.79e-05 | 2 | 225 | 2 | DOID:0110042 (implicated_via_orthology) | |
| Disease | X-24588 measurement | 1.18e-04 | 13 | 225 | 3 | EFO_0800898 | |
| Disease | alpha fetoprotein measurement | 1.21e-04 | 100 | 225 | 6 | EFO_0010583 | |
| Disease | non-high density lipoprotein cholesterol measurement | USP34 GC COL25A1 ZRANB3 BRCA2 UGT1A10 UGT1A8 UGT1A7 UGT1A5 SMC6 UGT1A9 APOB UGT1A4 UGT1A1 UGT1A3 PBRM1 | 1.28e-04 | 713 | 225 | 16 | EFO_0005689 |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.41e-04 | 147 | 225 | 7 | DOID:9352 (biomarker_via_orthology) | |
| Disease | common carotid intimal medial thickness | 1.62e-04 | 67 | 225 | 5 | EFO_0004860 | |
| Disease | rectum cancer (is_marker_for) | 1.73e-04 | 3 | 225 | 2 | DOID:1993 (is_marker_for) | |
| Disease | refractive error | A2M MYO5B ACO2 AKAP6 SLC12A6 FLT1 RASGRF1 CNKSR2 XPNPEP3 CTBP2 | 2.18e-04 | 326 | 225 | 10 | MONDO_0004892 |
| Disease | prostate cancer (is_implicated_in) | 2.84e-04 | 117 | 225 | 6 | DOID:10283 (is_implicated_in) | |
| Disease | Childhood Medulloblastoma | 3.22e-04 | 43 | 225 | 4 | C0278510 | |
| Disease | Melanotic medulloblastoma | 3.22e-04 | 43 | 225 | 4 | C1275668 | |
| Disease | Medullomyoblastoma | 3.22e-04 | 43 | 225 | 4 | C0205833 | |
| Disease | Desmoplastic Medulloblastoma | 3.22e-04 | 43 | 225 | 4 | C0751291 | |
| Disease | Adult Medulloblastoma | 3.22e-04 | 43 | 225 | 4 | C0278876 | |
| Disease | late-onset Alzheimers disease | RAPGEF5 COL25A1 MEI4 BIN1 UGT1A10 UGT1A8 CNKSR2 STK31 CTNND2 | 4.34e-04 | 292 | 225 | 9 | EFO_1001870 |
| Disease | spermidine measurement | 5.70e-04 | 5 | 225 | 2 | EFO_0021802 | |
| Disease | Duane Retraction Syndrome | 5.70e-04 | 5 | 225 | 2 | C0013261 | |
| Disease | Medulloblastoma | 5.76e-04 | 50 | 225 | 4 | C0025149 | |
| Disease | testosterone measurement | HAUS6 MYO5A ERCC6L UGT2A2 COL25A1 ARHGEF9 TRIM38 DOCK3 UGT1A10 UGT1A8 UGT1A7 CECR2 UGT1A5 DNAH2 UGT1A9 JMJD1C OPHN1 UGT1A4 SEMA3D MYO15A RNF212B | 8.08e-04 | 1275 | 225 | 21 | EFO_0004908 |
| Disease | early-onset Parkinson's disease (implicated_via_orthology) | 8.51e-04 | 6 | 225 | 2 | DOID:0060894 (implicated_via_orthology) | |
| Disease | Asphyxia Neonatorum | 8.51e-04 | 6 | 225 | 2 | C0004045 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 8.86e-04 | 145 | 225 | 6 | DOID:1289 (implicated_via_orthology) | |
| Disease | Acute Confusional Senile Dementia | 9.86e-04 | 99 | 225 | 5 | C0546126 | |
| Disease | Alzheimer's Disease, Focal Onset | 9.86e-04 | 99 | 225 | 5 | C0750900 | |
| Disease | Alzheimer Disease, Early Onset | 9.86e-04 | 99 | 225 | 5 | C0750901 | |
| Disease | Presenile dementia | 9.86e-04 | 99 | 225 | 5 | C0011265 | |
| Disease | Alzheimer Disease, Late Onset | 9.86e-04 | 99 | 225 | 5 | C0494463 | |
| Disease | serum metabolite measurement | RGSL1 PSEN2 GC AGBL1 DNMT1 RASGRF1 UGT1A10 UGT1A8 UGT1A7 UGT1A5 UGT1A9 APOB SACM1L UGT1A4 UGT1A1 UGT1A3 NCOA7 | 9.98e-04 | 945 | 225 | 17 | EFO_0005653 |
| Disease | Familial Alzheimer Disease (FAD) | 1.03e-03 | 100 | 225 | 5 | C0276496 | |
| Disease | Alzheimer's Disease | 1.08e-03 | 101 | 225 | 5 | C0002395 | |
| Disease | Acute kidney injury | 1.08e-03 | 101 | 225 | 5 | C2609414 | |
| Disease | Acute Kidney Insufficiency | 1.08e-03 | 101 | 225 | 5 | C1565662 | |
| Disease | Kidney Failure, Acute | 1.08e-03 | 101 | 225 | 5 | C0022660 | |
| Disease | cancer (implicated_via_orthology) | 1.10e-03 | 268 | 225 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | vitamin D measurement | 1.17e-03 | 336 | 225 | 9 | EFO_0004631 | |
| Disease | Liver Cirrhosis | 1.18e-03 | 103 | 225 | 5 | C0023890 | |
| Disease | Early-onset autosomal dominant Alzheimer disease | 1.19e-03 | 7 | 225 | 2 | cv:CN043596 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 1.24e-03 | 28 | 225 | 3 | DOID:5409 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SYKENIMRLSSLHKD | 436 | P35503 | |
| HRMKKYLSKTGREDI | 301 | Q99798 | |
| YSDLDFEKVMHTRKR | 1466 | O60241 | |
| IMVKEAISFLERHSK | 266 | P54793 | |
| KELEEKVMELHKSYR | 361 | P11171 | |
| DVTYVKKVRTLRMHL | 1151 | P04920 | |
| DSILREMLSKKHAAY | 316 | Q15059 | |
| LTRLKEHYEKKMRDL | 311 | O15013 | |
| SLMLKEAVSYIERHK | 276 | P51689 | |
| REQHESIVMGLTKKY | 356 | O94986 | |
| YMKNIHKKEIDLRTS | 161 | Q8TF27 | |
| DYMKNIHKKEIDLRT | 366 | Q5VTM2 | |
| TTREELYKMLAHEAL | 101 | A6NH57 | |
| SMTDKYRLHLSVADL | 71 | P61073 | |
| MYHTITLTREDLEKF | 81 | P56545 | |
| ETLDRYMVKHKSHLR | 516 | Q6P1J9 | |
| VSKKLEMHVYSKRLE | 601 | Q9UKF6 | |
| EDMQLSYIHSKVKVI | 821 | P26358 | |
| LTMKEHLELYAAVKG | 1296 | Q8WWZ4 | |
| AHLTSKMVGDIRKYV | 861 | O94812 | |
| SFLRKAMKYEDTQHI | 1341 | P16157 | |
| SKYILRMLDRHTLNK | 286 | Q5XX13 | |
| HKVLRESGLKYVAVM | 136 | P30043 | |
| MEKIISEKLHYELEA | 141 | Q16589 | |
| LLLKYFHKDVIAEMS | 2286 | Q86UQ4 | |
| SLKETIYHLMKSSFI | 2331 | Q86UQ4 | |
| IKDSVMVLSATHRYK | 246 | O43741 | |
| YSIKLTEKLNMVTLH | 771 | Q96PN6 | |
| LDDYHEKMVAELTRK | 296 | Q8N865 | |
| TAMYKVLDVVKAHKD | 441 | Q9BXF3 | |
| KELIGKYAMRDLVHR | 926 | Q9UQB3 | |
| LVAYRVAKEKMAHTA | 66 | Q8TCP9 | |
| MHRAKVDYETKKTAI | 2701 | Q8IZT6 | |
| LKRKEYEMKLHTEAQ | 311 | P01023 | |
| YTALMTHLDILEKSV | 736 | Q96MI9 | |
| IMSTERHYIKHLKDI | 111 | O43307 | |
| LLAVYRMHSAEGRKK | 221 | Q8NH16 | |
| FYKHRITKLETAMQE | 91 | A8MTL3 | |
| KLFLEGMHYKRDLSI | 161 | Q9UJ41 | |
| MAAHLKKRVYEEFTK | 1 | Q96HW7 | |
| LKLNKDLYVHTMRTL | 206 | Q75QN2 | |
| MTYRLHKELVSAAKS | 461 | O60890 | |
| ISYEDVKLTILVKHM | 1336 | O75747 | |
| MRLITDSKVKLKYQH | 246 | Q9Y4X5 | |
| SKYILRMLDRHTLNK | 286 | O95170 | |
| HKVTLKDKMITVTRY | 861 | O75140 | |
| SYKSIHAMAKDIDLL | 241 | Q86U86 | |
| MLYIRKISNIKEHLE | 271 | Q5VTA0 | |
| SIMEKDLTYSSVKRH | 236 | Q96P67 | |
| HAKRKTVTAMDVVYA | 76 | P62805 | |
| TKLVKNYRSHEALLM | 966 | Q9BXT6 | |
| HAETSKMKVLEYIAN | 391 | P43364 | |
| LRSYHETSKMKVLRF | 636 | Q9Y5V3 | |
| LSIKMRLEKEIETYH | 441 | P35527 | |
| HALYAMKTLRKKDVL | 691 | Q9NRM7 | |
| YIAELTLAIESVHKM | 771 | Q9NRM7 | |
| FLKHSAELVYMLESK | 381 | Q9NXD2 | |
| AELVYMLESKHLSVV | 386 | Q9NXD2 | |
| MYRVGVSKLFLKEHL | 1876 | Q9UKN7 | |
| LVSEHVIELLTKMYR | 971 | Q9UBC5 | |
| KTFLTEVKVMRSLDH | 371 | P53671 | |
| IYSKFHQKRMEELTE | 511 | Q6ZRQ5 | |
| LHAVMKKSYDNEKRL | 46 | Q5T655 | |
| IRKEAYVHKSVMEEL | 46 | P61326 | |
| YVHKSVMEELKRIID | 51 | P61326 | |
| QESSEAYMRKILLHK | 116 | O14990 | |
| LLDAMHTLREKYGIK | 1916 | Q15652 | |
| LIMFLHDLVSAYLKE | 4861 | Q2LD37 | |
| LSALYMHAKKVSSAI | 1636 | Q5CZC0 | |
| RDEEKIYHKMSISEL | 366 | P0DPD6 | |
| KAVVIHKSKYRDDMV | 321 | Q5JVS0 | |
| TIHKDRYKMKDLIRF | 851 | Q86YR7 | |
| SVLLHKRELMYTVEL | 346 | Q9NZN1 | |
| YSATRIAEHIAKEMK | 286 | Q9HCI6 | |
| LLAVYRMHSAEGRKK | 221 | Q8NG80 | |
| IYDRTSVLHVMVKKG | 206 | Q8NCN5 | |
| VELYKSSHRDKLGLM | 131 | Q76G19 | |
| LLAQKSYEHMAKIRI | 96 | Q9BXS0 | |
| IEKTMKRAYEKHVII | 421 | A0PJZ3 | |
| DKVLELLMYFTKHSD | 2171 | Q6KC79 | |
| MSLTSAYQHKLAEKL | 1 | P55160 | |
| SLYHSRMKDLKDFIR | 486 | Q9UQ05 | |
| VSKVMILVKATEYLH | 311 | P12525 | |
| SYKEFIGIMKDRLHR | 491 | Q86XE3 | |
| AIRKVEKMHKLLEVY | 341 | Q5JSP0 | |
| LQEVYHKSMTLKEAI | 181 | P28066 | |
| LYEVVETLSKLHLVM | 136 | Q8IY84 | |
| IHLRNAMTTRKKETY | 386 | Q9Y3T9 | |
| TYLEAHRIVKMNKSE | 296 | P33993 | |
| MLLLKKHTEDISSVY | 1 | Q6P2M8 | |
| EADKVRLSYLHIMSL | 31 | Q8IUM7 | |
| DIRKFSHMLLYLKEA | 51 | Q52LW3 | |
| ETLRYLMIHLKKVTM | 401 | P52757 | |
| QRRDEEKIYHKMSIS | 436 | P0DPD8 | |
| EKIYHKMSISELQAL | 441 | P0DPD8 | |
| ALDSIRYITRHIMKE | 396 | P30532 | |
| RARYHMKADSVVDLL | 1386 | P04114 | |
| ELRKHKLIDVISMYR | 4256 | P04114 | |
| KVISRMLEENEKYRH | 146 | Q569G3 | |
| IKYDENMVLVSLLKH | 201 | O95352 | |
| YTKILEVMHTKKRLL | 1746 | Q5JSL3 | |
| KDMKRDLYIVAHVIR | 281 | Q8IZD9 | |
| LHSDIRKNKMDILSY | 1466 | P51587 | |
| LVETLHAARMEYKDL | 346 | P0C221 | |
| MKHEKDRLLLSEHYS | 2946 | Q9H799 | |
| TEFDARKLHKLYKMA | 1541 | O14647 | |
| SREVDALKEKIHEYM | 716 | Q4L180 | |
| RLHLSTQKMYELKTK | 231 | Q5T197 | |
| THMEDKVSLDIYSRL | 401 | Q96LA6 | |
| MTLLHFIALTVKEKY | 806 | Q8IVF7 | |
| QLRLSMDIDVSYKHK | 1306 | P01031 | |
| DDTYTKRQLLKMEHL | 316 | P78396 | |
| HTSKMRYKEDDLVKR | 226 | Q5T3F8 | |
| MLHTKIVNRKTTIYE | 331 | Q6K0P9 | |
| YAEELAKHGMKVVLI | 66 | Q53GQ0 | |
| TEEHVDKMYLNILRK | 436 | Q5TB80 | |
| TLKTMKISRFERHLY | 411 | O00458 | |
| KHYREMEEKSALIIQ | 381 | Q15051 | |
| LKHMRYRIKDDLTTI | 351 | Q7Z4H7 | |
| YMQSVELKKRHLEES | 646 | Q12840 | |
| INYEKETRLEHMAKL | 221 | Q9UH77 | |
| IMLSYIRSKKLEHSN | 61 | P15382 | |
| VHKMVVESAYEVIKL | 231 | P07195 | |
| YLMAHLKRVTLHEKE | 396 | P15882 | |
| ELKENLKDTMTKRYH | 121 | P48509 | |
| RTYLASVKAMHEASK | 66 | O00499 | |
| IQKSLDMYLETKRHI | 1516 | Q9P225 | |
| MKKDLATFLYHLRIE | 956 | Q9UHW9 | |
| RMHAKKLSYTVEVLL | 371 | Q9UDX3 | |
| ILIERAMKDIHYSVK | 131 | Q9Y3A5 | |
| DVLSYKKTMLHLTDI | 96 | Q9NTJ5 | |
| LIKYSVDRHTDMDRI | 416 | Q9ULB4 | |
| TLTKIIEARLKMYKH | 91 | P20618 | |
| LLRLVHEDYTLKMSS | 356 | Q9UNU6 | |
| YRKFVSLDHIKELLM | 381 | Q2NKX8 | |
| KLQEALMHYKEAIRI | 376 | O15294 | |
| SELELAKMTMLLLYH | 91 | Q14980 | |
| TKDAQHALRRTMEKY | 141 | P40938 | |
| SIQMKKDLTTFLYHL | 891 | Q9H2X9 | |
| EMKLHRKLTVEENYR | 1001 | Q96PC5 | |
| TRAKAAKELQHYVTM | 36 | P42345 | |
| HLKDKLEEYMARFSK | 186 | Q49A17 | |
| KKDLLEEKIMYSHLI | 271 | O95837 | |
| EAYVHKSVMEELKRI | 51 | Q96A72 | |
| DKSSREYTEHLAMLL | 26 | A8MW99 | |
| IRVALMEKHLSEYIS | 146 | Q96NL0 | |
| MEKHLSEYISTALRD | 151 | Q96NL0 | |
| KETRISSLEKDMHYA | 301 | A5PLK6 | |
| VSKLYFDVKKMLRSH | 276 | O00635 | |
| HTMVDLKDLKGYSRI | 171 | Q9H8W5 | |
| SYKLVSEMVKKLHAA | 801 | Q8TF05 | |
| EELTLKYGAKHVIML | 71 | P49768 | |
| RDKETKIIHMRDIYS | 151 | Q86VY9 | |
| LKRAHVDMYVRKLKE | 201 | Q86TJ2 | |
| LVLVKELNARYMHKI | 266 | Q7LBE3 | |
| LEGALKIKEITYMHS | 571 | Q06210 | |
| KIKEITYMHSEGILA | 576 | Q06210 | |
| VSIALYNDISHMKIK | 276 | Q8NI08 | |
| MKDNDIKRLLYTHLL | 1 | Q07326 | |
| SVRIHLLTKMADIEY | 296 | P40937 | |
| KDSIRDVHIKGIMYR | 251 | Q86UY8 | |
| AHYILKSLEDIDMLL | 271 | Q96NG3 | |
| KEYVSLGALKMHIRT | 166 | O43623 | |
| EHSKMFLKTIYRNVL | 166 | Q92565 | |
| HFKLVMKAYRDTIKI | 336 | Q6PI26 | |
| YKRKMLLARHSLDQD | 646 | Q9UL54 | |
| STLRVEVKYHKNDML | 1016 | P14410 | |
| AVLHILMKKDYSTSK | 716 | P40879 | |
| HSEKTMYLKSSDNRL | 721 | Q92854 | |
| HRSLIMKKLTYAKET | 161 | Q9BZV3 | |
| AHILYMSLEKLKFID | 106 | Q9NUC0 | |
| YAKSKLEELSRIMHD | 411 | Q13972 | |
| ILEMAVSYLKHSKAF | 61 | Q5TA89 | |
| DVISFIKRHSVMYKS | 416 | O95025 | |
| THYRLELMEKDLCVK | 91 | Q08945 | |
| AEKLMTILFETYRSH | 31 | Q9NY30 | |
| RYSVEMSIRHLKKTE | 1001 | Q13023 | |
| LDHEYLSDTTLEKKM | 21 | Q8TED9 | |
| ALKAKYTLLHDAVMS | 66 | Q8IYE0 | |
| DYMKNIHKKEIDLRT | 321 | A6NIR3 | |
| TVEVVKLMIKDYFHI | 21 | A6NFN9 | |
| FHTIMKQLLSYITKD | 1186 | Q15021 | |
| KLAYQVLAEKVHMRA | 226 | Q9BPX3 | |
| KLVVAHMTKSELYLQ | 311 | Q8WUD6 | |
| MHYDAEIILKRETLL | 121 | Q96S66 | |
| EHRISTKMEYKLSFI | 926 | Q8WXI2 | |
| HLEYTLKTYIDTRMK | 351 | Q9BXU1 | |
| LDHMRAKTKYVKIVE | 146 | Q9Y3V2 | |
| MKSRYTTEFHELEKI | 291 | P30291 | |
| EAYIDARTLRKHMTK | 921 | O95625 | |
| KSYKENIMRLSSLHK | 431 | Q9HAW8 | |
| IAMKTLLKFTRHDYI | 481 | Q8IZQ1 | |
| YKKLEIKHAIEMAET | 556 | Q9UBY0 | |
| SNMIHSYIKEIEDLR | 476 | Q7Z4S6 | |
| YIHLLAMKIKVGSDD | 711 | Q9BQI7 | |
| ADLEATLRHKLTVMY | 196 | Q14258 | |
| KHIKIMTAEGLYRIT | 716 | P15498 | |
| RKLYRDVMLETFKHL | 26 | Q9HAH1 | |
| YKENIMRLSSLHKDR | 436 | P22309 | |
| KVMDKYTFELSRRTH | 341 | P02774 | |
| SYKENIMRLSSLHKD | 436 | P35504 | |
| EEELTLKYGAKHVIM | 76 | P49810 | |
| IKLLGEIMEHRFKTY | 916 | Q96SB8 | |
| MKHYEVEILDAKTRE | 1 | Q9NZ01 | |
| LHYDIQKSLLMKIDA | 121 | Q9H857 | |
| KSYKENIMRLSSLHK | 431 | O60656 | |
| HTLSYLVKELEVRMD | 561 | Q96AE7 | |
| HDKAKEYIDRMLKIS | 126 | Q8NDW8 | |
| LDYFKTEHKLEITML | 976 | P22314 | |
| ESIDLYQVIHKMRHK | 496 | Q96MU7 | |
| KTLYISDSDKRKHFM | 126 | Q06330 | |
| HTLLMFLYIIKTKES | 526 | Q96SK2 | |
| EYALRRHKLMSLIQK | 71 | Q9NQH7 | |
| FMYDEHIKSRLIKDI | 856 | Q2M389 | |
| KSYLLVHIRMHTGEK | 326 | P17031 | |
| SELKEHMKTHYKIRV | 166 | Q9UL36 | |
| RNIEKISMLEKIYIH | 436 | P00734 | |
| IKAHLEYRSAEMEKS | 251 | O95361 | |
| SKYLDIHERMGKKLT | 56 | P62072 | |
| LYSLSKEGMEKHIKR | 741 | Q9C0G0 | |
| KYSEDMKHKTTLLEL | 1926 | Q70CQ2 | |
| LYREETAKMKEHKAI | 766 | Q9UNX4 | |
| TLKKYSVHLEDMATN | 196 | Q9HBM0 | |
| EYKALMTELKILTHI | 871 | P17948 | |
| ELYKGMTEHTKNLLR | 161 | Q9NRD5 | |
| EKMKYLNLSSTRIHS | 436 | O60603 | |
| AKMLDHEYTTKEIFR | 261 | P11387 | |
| ILLLEYKTKAEMSHI | 771 | Q96QT4 | |
| KSYKENIMRLSSLHK | 431 | Q9HAW7 | |
| SYKKSNIDSLIEHMI | 86 | P0DTE5 | |
| LKEHMKLHSDTRDYI | 376 | Q9BU19 | |
| KSYKENIMRLSSLHK | 431 | Q9HAW9 | |
| IEYTHMLRVTKTFVK | 126 | Q9Y487 | |
| FKVVIVDESHYMKSR | 151 | Q5FWF4 | |
| SYKENIMRLSSLHKD | 436 | P22310 | |
| RYMKKLENKDISLVH | 536 | P23378 | |
| LYAAKDLEKHTMVIE | 5411 | O14686 | |
| HKIRYMKETTFAELI | 271 | Q86W25 | |
| EARSVERYKKLHIGM | 911 | Q9Y4I1 | |
| TMEVERLKKELVHYQ | 956 | Q9ULV0 | |
| VSKEKITRMLEHYQR | 561 | Q86UW6 | |
| KDYAHIRSAMKILQF | 296 | Q6PIF6 | |
| AHMLKTRNDYKLVTD | 4881 | P20929 |